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Introduction 
1. Introduction 
 
Many organs of animals, including lung, kidney, blood vessels and most of glands in vertebrates, 
are built of branched tubular epithelial structures. They enable the transport of gases or liquids in 
the body. How they form and what controls branching events, direction of growth and tube size are 
questions that are pertinent to understanding branch morphogenesis. These questions are important 
not only for biology but also for medicine, because many diseases, such as polycystic kidney 
disease, are causing plumbing defects. The elucidation of molecular mechanisms of tube formation 
could lead to new ways of diagnosing and treating such diseases. However, dissection of these 
processes in mammalian system is rather difficult. Thus the Drosophila tracheal (respiratory) 
system with its structural simplicity and accessible genetics has become an excellent model in 
recent years for studying tubulogenesis.  
 
1.1 Development of Drosophila tracheal system 
 
The Drosophila tracheal system is a network of single-layered epithelial tubes transporting oxygen 
and other gases throughout the body. It is comprised of approximately 1600 cells forming ~ 10,000 
interconnected tubes in the larval trachea (Ghabrial et al., 2003). They are covered by a luminal 
cuticular lining, which provides a barrier against dehydration and pathogens. The process of 
tubulogenesis is based on cell migration, cell shape changes and rearrangements and regulated 
growth of distinct subcellular domains. The Drosophila trachea arises from ten clusters of 
ectodermal cells on either side of the embryo, which results in bilateral symmetry and a repeated 
metameric structure of the network. After two cycles of cell division, ~ 80 cells of each tracheal 
placode invaginates to form an elongated sac, from which six major buds grow in different 
directions, giving rise to the different primary branches. The major primary branch is the dorsal 
trunk (DT) –connecting all tracheal segments along the anterior-posterior axis. On the lateral side 
this role is played by the lateral trunk (LT). The transverse connective (TC) connects the DT and the 
LT in each segment. Among the remaining primary branches are the dorsal branches (DB) 
migrating dorsally, the visceral branches (VB) migrating internally and the ganglionic branches 
(GB) penetrating the central nervous system. The primary branches later produce secondary 
branches, with their lumen formed by a single cell. The terminal branches arise from the tips of the 
secondary branches during stage 16 of embryonic development and their formation last throughout 
the larval stages. During their development the terminal tracheal cells ramify into extensive arrays 
that cover and support large area of the target tissue (Manning and Krasnow, 1993). Fig.1.1 depicts 
the development of the embryonic trachea and the fully formed larval tracheal tree. 
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Figure 1.1 Schematic representation highlighting the development of the embryonic trachea (A) and the larval respiratory 
system (B). After placode invagination at stage 11, cells form elongated sacs from which six major buds grow out giving 
rise to primary branches (stage 12). One example of tracheal metamere at stage 12 is depicted in the upper right panel.  
The formation of the buds is followed by cell migration, branch fusions and extensive cell rearrangements which lead to 
formation of a network supplying all target tissues with oxygen by stage 17. During the larval life terminal branches 
undergo several ramifications generating variable and complex tracheoles. (Adapted from Hartenstein, 1993 (A) and 
Ghabrial et al., 2003 (B)). 
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Proper development of the trachea requires induction and maintenance of expression of the 
Fibroblast growth factor (FGF) receptor, Breathless (Btl) in each tracheal cell. The FGF pathway 
plays a major role in the branching process. It is first activated by the FGF-like molecule, 
Branchless (Bnl), secreted by groups of ectodermal cells surrounding the invaginated placode. Bnl 
acts as a chemoattractant for the nearest tracheal cells and guides cell migration thereby directing 
branch outgrowth (Sutherland et al., 1996). This signalling pathway is used in each step of 
branching, triggering the expression of different genes required for primary, secondary or terminal 
outgrowth. Although some such genes have been identified, it is still not entirely clear what 
happens in the cell after Btl activation. The genetic developmental program controlling primary and 
secondary branching involves other signalling pathways as well, like Epidermal growth factor 
(EGF), Decapentaplegic (Dpp), Wingless (Wg) etc, responsible for determination of cell fates and 
branch types. In contrast to stereotyped embryonic development of the trachea, formation of 
terminal branches in the larva is more flexible and depends more on the physiological needs of the 
surrounding tissues. (Ghabrial et al., 2003; Kerman et al., 2006; Uv et al., 2003). 
  
1.2 Architecture of tracheal branches 
 
Different branches within each tracheal metamere have a fixed number of cells and a characteristic 
tube dimensions and structures. They are all made up of polarized epithelial cells, with the apical 
surface facing the lumen and the basal side facing the surrounding tissue. In late embryonic and 
larval stages, four distinct types of tubes can be found (Fig. 1.2 and 1.3).  
Type-I tubes – DT, part of TC – are multicellular tubes with two to five wedge-shaped cells 
surrounding the central lumen and connected by intracellular junctions. Their diameter in the 
embryo ranges from 4 – 5 μm. Type-II tubes are more narrow (1 μm in diameter), formed by 
interconnected cells lying in a row. They are found in DB, VB, GB, LT and parts of TC. Their 
lumen is made up of a single, tube-shaped cell sealed by autocellular junctions. To maintain the 
chain-like assembly of cells, adjacent cells are connected by ring-shaped intercellular junctions. 
Type–III tubes (fusion anastomoses) interconnect tubes of type I and II (DT, LT and DB) in order to 
link up neighbouring metamers and form a continuous network. They consist of two single 
doughnut-shaped cells attached head to head through an intercellular junction. Each of the two cells 
derive from a different primary branch and they contact each other to mediate lumen fusion. This 
results in seamless tubes lacking intracellular junctions. The diameter of type-III tubes depends on 
the type of the connected tubes and varies from ~ 0.5 to 5 μm.  Type-IV tubes are formed by 
terminal cells. They are subcellular seamless capillaries making direct contact with target tissues 
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and mediating gas exchange. Their diameter is less than 0.5 μm (Kerman et al., 2006; Uv et al., 
2003).  
 
 
Figure 1.2  Each metamere consists of different types of branches. The tracheal system in a stage 16 embryo, visualised 
by luminal marker (2A12) (A), and schematic representation of one metamere (B). In the late embryo and in larval 
stages, four different tube types can be distinguished. Adapted from (Uv et al., 2003). 
 
 
 
Type-I Tube Type-II Tube Type-IV Tube
 
 
Figure 1.3 Schematic cross sections of the lumen of different tube types. The cell body is marked in green and nuclei in 
red. 
 
 
 
 
 
 4
Introduction 
1.3 Morphogenesis of tracheal branches 
 
The formation of elongated tracheal branches with different tube types from the sac-like structure of 
the invaginated placode requires cell rearrangements and cell shape changes. Since tracheal cells are 
part of a tightly sealed epithelium, the epithelial adherens junctions, responsible for cell-cell 
adhesion, also undergo extensive remodeling during formation of branches. 
 
 1.3.1 Primary branching 
 
The first branches to form are multicellular type-I tubes, consisting of several cells wrapped around 
the lumen and held together by intercellular adherens junctions (AJs) established at a subapical 
position between neighbouring cells. Their formation is based on invagination of the tracheal 
placode and further migration of cells, without dramatic changes in cell to cell contacts. Throughout 
tracheal development, only large tubes like DT or more dorsal parts of TC keep this character. Finer 
secondary branches which arise from primary branches during trachea morphogenesis undergo 
more drastic rearrangements. 
 
1.3.2 Secondary branching 
 
Transition from type–I tubes to type II, accompanied by tube elongation, can be divided into 
distinct steps. They were revealed by in vivo analysis of AJ rearrangements during the formation of 
dorsal branches (Jazwinska et al., 2003; Ribeiro et al., 2004). In the first step referred to as 
‘pairing’, cells are aligned in a pairwise fashion along the lumen, made up of two cells. Afterwards, 
cells start to intercalate, which requires extensive AJ remodelling. First, two neighbouring cells 
reach around the lumen, which leads to the formation of the first autocellular AJs as a cell touches 
its own membrane extension. Both cells reach around the lumen on opposite ends, proximal and 
distal, along the elongation axis. As the first autocellular contact is established, cells seem to ‘zip 
up’ by replacing intercellular AJs with autocellular ones. This step is referred to as ‘zipping’. To 
ensure that cells stay in contact with their neighbours in a head to tail arrangement, the zipping 
process must be terminated. This results in the presence of small, ring-like intercellular AJs 
connecting neighbouring cells. 
So far not much is known about the molecular events underlying transition from type I to type II 
tubes.  It has been shown that zinc-finger transcription factor Spalt (Sal) is requird for the control of 
this process, by blocking intercalation (Ribeiro et al., 2004). Sal expression is spatially induced by 
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wingless signalling in dorsal trunk (Chihara and Hayashi, 2000; Llimargas, 2000) and repressed by 
dpp signalling in cells positioned dorsally and ventrally to the dorsal trunk (Chen et al., 1998). This 
expression pattern  defines branches in which intercalation takes place. However, it is not clear how 
this happens, since no Sal target genes have been found so far. Little is known also about molecules 
involved in cell pairing, cells reaching around the lumen or in the zipping process. It is likely that 
regulation of cell adhesion is required for these steps. DE-cadherin regulation might be important 
for this process as it is involved in cell adhesion. DE-cadherin is a single–pass transmembrane 
protein. Its extracellular domain forms homophilic transdimers between adjacent cell membranes. 
The cytoplasmic domain interacts with p120 catenin, β-catenin and Hakai, an E3-ubiquitin ligase 
(Fujita et al., 2002). β-catenin binds to α-catenin, which associates with actin filaments. The cell to 
cell contact based on the strong adhesivness of cadherin is caused probably by anchoring of 
cadherin-catenin complexes to the cytoskeleton and has to be modulated to allow cell 
rearrangements. It is possible that regulation takes place at different levels. It could be for example, 
control of E-cadherin turnover or recycling, modulation of interaction with the cytoskeleton, or 
regulation of adhesion through inside-out signalling (Neumann and Affolter, 2006). There are 
several possible candidates shown to be involved in the intercalation process: Src, shown to induce 
the dissociation of epithelial cells, Hakai, targeting E-cadherin for degradation (Fujita et al., 2002), 
Arf6, a GTPase mediating E-cadherin internalization (Paterson et al., 2003). There are a number of 
proteins that might play a role in regulation of the actin cytoskeleton - E-cadherin interaction. These 
are for example small GTPases like Rho, Rac and Cdc42 and the Ras family member Rap1. Also, 
components of AJs might be involved in regulation of cell intercalation (Neumann and Affolter, 
2006).  Some of the genes listed above have been already shown to cause tracheal defects, like Src 
(Takahashi et al., 2005) or the GTPase Rac1 (Chihara et al., 2003). 
Two genes, piopio (pio) and dumpy (dp), have been shown to be required for the termination of cell 
intercalation, (Jazwinska et al., 2003). In their absence, all fine tubes are transformed into epithelial 
cysts, disconnected from the remaining multicellular tubes in the embryo. They both encode 
proteins containing zona pellucida (ZP) domain, they are produced by tracheal cells and secreted 
into the lumen. It has been proposed that Pio and Dp might form a luminal scaffold that prevents the 
complete zipping of the autocellular junctions and thus helping to preserve branch integrity. 
 
1.3.3 Fusion cell formation 
 
As the tracheal system develops from 20 independent metameres, branch fusion is needed to form a 
continuous network. Thus, cells at the tips of the connecting branches undergo a complex process of 
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partner recognition and formation of an intracellular tube. Fusion type-III tubes are doughnut-
shaped and lack autocellular junctions (Samakovlis et al., 1996a). They are formed in a process 
know as anastomosis in which fusion cells recognize each other, make contact on their basal surface 
and subsequently generate the apical lumen that bridges the junction between them. The initial 
lumen is provided by the apical surface of the bordering cells of branches to be fused. It is pulled 
along or penetrates the fusion cell actively, forming finger-like extensions. The lumen growth inside 
the fusion cell occurs in a proximo-distal orientation, with an increased number of vesicles 
containing luminal material at the tip of the growing lumen. This observation made by Samakovlis 
et al. (1996a) indicates that the intracellular lumen forms by assembly and fusion of vesicles, using 
the ‘finger’ tips as nucleation points (Uv et al., 2003).  
The first molecular step in a fusion event is the deposition of DE-cadherin at the site of contact on 
the basal surface of the cells (Tanaka-Matakatsu et al., 1996). This leads to accumulation of several 
cytoskeleton binding proteins, including α – catenin, β – catenin, short stop, which encods a plakin 
that binds both F-actin and microtubules and Formin 3, a regulator of several actin-based processes 
(Tanaka-Matakatsu et al., 1996; Lee and Kolodziej, 2002; Tanaka et al., 2004). These proteins 
mediate the formation and maintenance of an actin bridge that spans both fusion cells from one 
initial lumen bud to the other. This bridge serves as a site of fusion of vesicles with luminal 
material. Subsequently DE-cadherin and associated proteins form a circle perpendicular to the 
presumptive lumen at the interface between the two fusion cells. After docking and fusion of 
vesicles lead to the formation of a continuous lumen, the adherens ring expands to the same 
diameter as the connected tubes and two fusion cells form bicellular anastomosis.  
The number of cells undergoing the process of fusion is controled by Notch signalling as well as 
expression of fusion cells markers such as Escargot, Fusion-2 and Fusion-3.  Determination of 
fusion cell fate is a result of spatial interplay of Dpp, FGF and Wg signalling (Ikeya and Hayashi, 
1999; Steneberg et al., 1999). 
 
1.3.4 Terminal branching 
 
The tip cells on the secondary branches that do not form fusion cells form terminal branches. The 
initially compact cells grow thin cytoplasmic extensions towards the bnl expressing target tissue. 
The extensions finally come into close contact with the plasma membrane of target cells in order to 
allow gas diffusion. Their outgrowth is accompanied by repeated events of cytoplasm extension and 
formation of the lumen within the cell which leads to the creation of a ramified network contacting 
almost every cell in target tissues (Guillemin et al., 1996).   
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As terminal cells start to sprout, they also change their shape by extending broad cytoplasmic 
processes away from the neighbouring stalk cell. The nuclei are initailly moved along and initial 
branch lumen, possibly provided by neighbouring stalk cells, is acquired. During the further 
branches outgrowth the nucleus of the terminal cell remains stationary at the cell base. As 
branching proceeds, first long narrow cytoplasmic protrusions are formed which are later invaded 
by lumen. Similar to the lumen in fusion cells, it grows in a proximo-distal orientation, possibly by 
fusion of luminal vesicles (Guillemin et al., 1996). However, the mechanism leading to the 
formation of the lumen as a junction-less, intracellular, membrane-bound channel is poorly 
understood.  
The first steps of terminal branch formation during late embryogenesis seem to be stereotyped to 
ensure air supply to all regions of the newly hatched larvae. Larval life however, is dominated by 
extensive body growth and enhanced oxygen needs, which requires a more flexible system. The 
terminal branches ramify several times during this period, generating variable and complex trees of 
tracheoles. However, branching variability does not mean disorganization. Spacing between 
branching points is regular and branches never cross each other. Sprouting is regulated by oxygen 
needs of the tissues. Low oxygen (hypoxia) induces terminal branching and high oxygen 
(hyperoxia) suppresses it via control of branchless expression (Jarecki et al., 1999). It is not fully 
understood how the Drosophila cells sense low oxygen and how this leads to induction of 
branchless expression. It has been proposed that the Drosophila homologue of mammalian hypoxia 
inducible factor (HIF), the transcription factor playing a major role in mammalian hypoxia 
response, may mediate sensing and response to oxygen levels. In corcondance with this notion 
branchless has been identified as one of its targets. The other candidate is nitric oxide (NO) 
signalling, since its perturbation during larval life affects terminal branching in a fashion similar to 
hypoxia or hyperoxia (Ghabrial et al. 2003).  What happens in the terminal cells upon FGF signal 
activation by Bnl binding to the receptor Btl is also not fully understood, but some players have 
been identified. One of them is blistered (bs, named also pruned), the Drosophila homologue of 
mammalian serum response factor (SRF). It is selectively required for terminal branch growth, 
since in embryos missing DSRF, terminal cells undergo the initial sprouting but fail to develop an 
intracellular tube distal to the nucleus. It is a transcription factor whose activation in terminal cells 
by the FGF pathway induces expression of so far unknown target genes required for cytoplasmic 
outgrowth and terminal branch formation (Affolter et al., 1994; Guillemin et al., 1996).  One other 
identified regulator of terminal outgrowth is sprouty (spry). It acts downstream of FGF signalling, 
but as a negative regulator, antagonising the pathway and limiting the number of cells producing 
terminal branches (Hacohen et al., 1998). 
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Extensive ramification of terminal branches during larval life requires not only proper outgrowth 
and lumen formation but also its maintenance and stability. A recent study (Levi et al., 2006) 
revealed that Drosophila Talin, a large cytoskeletal protein that links integrin cell-adhesion 
molecules to the cytoskeleton, is required for maintenance of the terminal branches. The integrin-
talin adhesion complex anchors mature terminal branches to their substrata and maintain luminal 
organization. If these complexes are absent, the lumen becomes disorganised and retracts from the 
branch which leads to the degeneration of lumenless branches. 
 
1.4 Control of tracheal tube size 
 
During embryonic and larval development, tracheal tubes not only remodel their structure but also 
dramatically increase in size and diameter. At the end of larval life, tracheal tubes would have 
expanded up to 40 times their initial size. Extensive studies of the mechanical and molecular bases 
of this expansion and its control revealed several aspects of this process. 
First insight into tube size changes came with the identification of eight mutations leading to 
abnormal tube elongation or irregular tube diameter (Beitel and Krasnow, 2000). This study showed 
that tube size is linked to branch identity and is not controlled by number, size or overall shape of 
the cells forming the tracheal tubes, but by coordinated regulation of apical surface. Further studies 
revealed that tube length and diameter are controlled independently. Thus products of genes playing 
a role in tube size control were divided into two categories: one involved in tube elongation control 
and second required for control of tube diameter. 
 
1.4.1 Genes involved in tube elongation control 
 
This category consists of genes causing an increase in tube length when mutated. They mostly 
encode components of pleated septate junctions (SJs), revealing a new role for these cell to cell 
junctions. The SJs are membrane structures found basal to the adherens junctions in many epithelia. 
They are functional analogues of vertebrate tight junctions, since they form a diffusion barrier for 
water and solutes between epithelial cells.  
Mutations in megatrachea and sinous lead to an increased tube size. They encode claudins (Behr et 
al., 2003; Wu and Beitel, 2004), four transmembranepass proteins whose homolougs form a 
paracellular barrier in vertabarte tight junctions. Also the bulbous (lachsin) phenotype is caused by 
a mutation in a cell adhesion molecule which localises to SJs (Llimargas et al., 2004). Ecstatic, 
which turned out to be a new allele of nervana2 encodes the β-subunit of a Na+/K+ ATPase , which 
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also localises to SJs. Also other components of SJs, like coracle, neurexin, gliotactin, and the α – 
subunit of Na+/K+ ATPase show similar defects in tracheal tube size when mutated (Paul et al., 
2003). Additionally, this study revealed that the function of SJs in tube size control is separate from 
the regulation of paracellular diffusion. How the SJs control tube elongation is not clear. It was 
proposed that a group of SJ genes could regulate relative levels of apical membrane components 
such as Crumbs and thus affect luminal expansion (Wu and Beitel, 2004). The other model suggests 
that SJs could regulate the apical extracellular matrix indirectly. The identification and analysis of 
two luminal chitin-binding proteins Vermiform and Serpentine, which, when mutated leads to tube 
elongation phenotypes similar to those of mutations in SJs components (Luschnig et al., 2006; 
Wang et al., 2006) revealed that late modification of the luminal chitin matrix is specifically 
required for tube length control. Additionally it was shown that SJs are necessary for the proper 
localisation and apical secretion of Vermiform. These results suggest that the second model 
involving indirect control of tube size through modifications of apical luminal matrix is more likely.  
 
1.4.2 Genes involved in tube diameter control 
 
The second category of tube size mutations consists of genes affecting tube diameter when mutated. 
They encode proteins involved in chitin biogenesis, secretion or maturation. The tracheal chitin is 
synthesized by Chitin synthase 1 (CS 1 – krotzkopf verkehrt) and deposited into the lumen where it 
assembles into a defined transient cable that expands in unison with lumen diameter growth 
(Tonning et al., 2005). Loss of this transient chitin matrix results in local tube dilation and 
constriction. Such phenotypes have been observed in mummy/cystic mutants, in which UDP-N- 
acetylglucosamine diphosphorylase required for chitin synthesis is mutated (Araujo et al., 2005; 
Devine et al., 2005). Also knickkopf (gnarled) and retroactive, which encode proteins involved in 
targeting and/or secretion of chitin or chitin synthesis enzymes are necessary for regular tube 
diameter expansion (Devine et al., 2005; Moussian et al., 2006). 
 
1.4.3 Model of tube size regulation  
 
Recently, Wang et al. (2006) proposed the following model. During tube expansion, assembly and 
growth of the chitin matrix is required to coordinate uniform radial expansion of the tubes. 
Subsequent modifications in chitin fibril structure by secreted deacetylases (Vermiform and 
Serpentine), whose localisation depends on SJ function, instruct the epithelial cells to terminate the 
tube elongation. Thus dynamic structural changes of the luminal matrix may independently 
determine diameter growth and tube elongation. 
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1.5 Phenotypic analysis of mutant clones using the MARCM system. 
 
Investigation of tracheal development during embryogenesis has been mostly based on analyses of 
homozygous mutant embryos. Such an approach is not always possible for studying tracheal 
morphogenesis during larval life as mutations in many of the genes involved in this process are 
embryonic lethal. This could be overcome by generation of genetically mosaic organisms. Induction 
of mutant clones surrounded by wild type tissue is a very useful tool for analysing the consequences 
of gene loss of function during animal development. The commonly used FRT/FLP system 
(Theodosiou and Xu, 1998) allows the generation of mutant clonal cells. Usually, the mutant cells 
can be distinguished from their twin spot sister cells and wild type cells by the loss of marker gene 
expression. However, in many cases it is very useful to mark the mutant cells positively through 
expression of marker. Therefore the MARCM (Mosaic Analysis with a Repressible Cell Marker) 
system was established in flies (Lee and Luo, 1999). In this system, expression of a GAL4-UAS 
construct with a reporter gene is suppressed by the presence of the GAL4 repressor GAL80, which 
is placed on the FRT chromosome whose homolog is carrying a mutation to be analysed. When a 
FLP dependent mitotic recombination event occurs, the reporter gene is expressed only in clones 
homozygous for the mutation (fig. 1.4).   
 
 
 
Fig. 1.4 The MARCM system. In parental cells, expression of reporter gene is suppressed by the presence of the GAL4 
repressor, GAL 80. The repressor gene is placed distal to the FRT-site on the homologous arm of the chromosome arm 
with mutation of interest. After FLP induced recombination the cells homozygous for the mutation loose the repressor 
gene and thus reporter gene can be expressed in these cells (Adapted from Lee and Luo, 1999) 
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The system has been wildly applied to investigate many cellular and developmental processes, 
including analysis of tracheal morphogenesis (Cabernard and Affolter, 2005; Ghabrial and 
Krasnow, 2006; Levi et al., 2006, A.Bilstein, PhD thesis). 
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1.6 The aim 
 
Several studies on tracheal development in recent years have given an insight into the complexity of 
the genetic control and cellular processes of tracheal morphogenesis. However there are still many 
open questions: what are the ‘effectors’ of signalling pathways controlling tubulogenesis, which 
molecules are involved in cell remodelling and how do they coordinate extensive cell shape 
changes and rearrangements. Also, not much is known about the molecular mechanisms responsible 
for the sprouting of cytoplasmic outgrowth and lumen formation in terminal branching. Since 
extensive cell remodelling, needed during terminal branching lasts up to larval stages it is important 
to be able to analyse these processes also at later stages of development. This is not always possible 
since many genes that might play a role in larval tracheal morphogenesis could be also required 
during embryogenesis. This disadvantage can be overcome by application of clonal analysis with 
the MARCM system. It has been successfully applied to analyse role of known genes in the later 
stages of trachea formation. Thus, it can be also used for identification of new genes involved in 
tracheal development, a different approach for a better understanding of this process. 
The aim of this study was to perform a genetic mosaic screen of the second chromosome, for EMS-
induced mutations affecting tracheal morphogenesis. The second chromosome was chosen, because 
the first and third were simultaneously screened by a different group. To identified new mutants 
affecting larval tracheal development we applied clonal analysis with the MARCM system and 
examined mutation effects in third instar larvae. 
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2. Material and Methods 
 
2.1 Materials 
 
2.1.1 Antibodies 
 
Primary antibodies: 
• mouse anti-m2A12 ; 1:20 (against unknown tracheal lumen protein , N. Patel); 
• rabbit anti- β – Gal; 1:500 (Cappel); 
• mouse anti-arm; 1:3000;   
• rabbit anti-GFP; 1:500; 
 
Secondary antibodies: 
• goat  anti-mouse, biotin; 1:500 
• goat anti-rabbit, biotin; 1:500 
• goat anti-mouse, Alexa 568; 1:500 
• goat anti-rabbit Alexa 488; 1:500 
 
2.1.2 Fly stocks 
 
Stocks listed in tab. 2.1 were used for experiments. TB170 line was used as a wild type control in 
MARCM analysis. For embryonic analysis w- flies were used. 
 
Stock 
number 
Genotype Reference 
TB170 yd2w1118P{ey-FLP.N}2 P{GMR-lacZ.C(38.1)}TPN1;P{neoFRT}40A Bloomington #5615 
TB114 yw,hsFlp1.22;tub-Gal80,FRT40A;btl-GAL4, UAS-GFP 
S.Luschnig (Krasnow 
lab) 
TL521 P{Hs-hid}sp/CyO8ftz lacZ R. Lehmann 
TB136 w-; If/CyO; btl-Gal4, UAS-βspectrin-PH domain-eGFP-2xHA A. Bilstein 
TMB013 yd2 w1118 P{ey-FLP.N}2 P{GMR-lacZ.C(38.1)}TPN1; P{EP}EP511/CyO Bloomington #6415 
TN044 w1118; ; P{UAS-myr-mRFP}2/TM6B, Tb1 Bloomington #7119 
F-232 w-; If/CyO; MKRS/TM6B F. Sprenger 
TMB017 w-; conv[K6507]/CyOwgLacZ G.Beitel 
TMB018 w-; nrv2[23B]/ CyOwgLacZ G. Beitel 
TMB19 w*; vari[K5953]/CyO G. Beitel 
 
Tabele 2.1 List of used fly stocks 
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2.1.3 General reagents and equipment 
 
• general chemicals: Boehringer, Fluka, Gibco, Merck and Sigma 
• plastic ware:, Eppendorf, Falcon, Greiner, Sarstedt 
• microscopes: Leica Fluorescent-Stereomicroscope MZFLIII (Fluo-Combi) 
Flourescent Microscope – Axioplan 2 imaging - Zeiss 
Light Microsocpe – Axioplan - Zeiss 
• cameras: AxioCam MRc5 – Zeiss 
AxioCam HRm - Zeiss 
 
2.2 Methods 
 
2.2.1 Mutagenesis and establishing of the stocks 
 
To establish 5000 lines carrying point mutations on the left arm of the second chromosome 
chemical mutagenesis was performed. To avoid difficulties of handling such a high numbers of 
lines at once, they were generated in batches of 1000 lines. In each round three hundreds  2–3 days 
old males from an isogenised stock, with FRT site on the left arm of the second chromosome 
(yd2w1118P{ey-FLP.N}2 P{GMR-lacZ.C(38.1)}TPN1;P{neoFRT}40A), were mutagenised with 
30mM EMS (standard protocol, Grigliatti, 1998). EMS fed males were crossed with hs-Hid/CyO 
females (P{Hs-hid}sp/CyO8ftz lacZ) (mass cross). To select progeny with required genotype 
(FRT40A, mutation/CyO) larvae were heat-shocked on day 5 and 6 after egg lay for 2 hours at 38O 
C (to induce the hsHid transgene expression).  Only larvae carrying the mutated FRT chromosome 
but lacking the one with hsHid transgene, survived this procedure. Next, 1000 males from the 
progeny were used to establish single lines by crossing them to hsHid/CyO females. Again selection 
for flies with correct genotype was performed by heat-shock treatment as described above (the 
crossing scheme is shown on fig.2.1).  
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Figure 2.1. Screen crossing scheme: The screen was performed in six batches. In each round 1000 lines were 
established and analysed in the way shown above.  
 
2.2.2 MARCM analysis 
 
The male progeny from stocks established as depicted in fig.1 were crossed with females carrying 
all components of the MARCM system (yw,hsFlp1.22;tub-Gal80,FRT40A;btl-GAL4, UAS-GFP). 
A UAS-GFP construct was used as a reporter gene, driven by the trachea specific btl-GAL4. The 
eggs were collected for 4 hours at 25OC and heat-shocked for 30 min at 38O C to induce mitotic 
recombination. Live third instar larvae were observed under a fluorescent-stereomicroscope. For 
live observation larvae were first immobilised by adding water to the vials and after 1 hour placed 
on the microscopic slide with plastic grid preventing disturbance of larval structure by cover slip. 8 
larvae were analysed per line. Each line showing a defect was retested on the next day with 16 
larvae. 
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2.2.3 Complementation test 
 
In order to perform a complementation test, all the lines were checked for lethality. The 
homozygous lethal lines were identified by absence of non- CyO flies after 4 generations. Later, 
these lines were tested against each other within the phenotypic groups. Approximately 2 males and 
4 females were taken for each cross. The crosses were kept at 25oC and progeny was scored for 
presence of non-CyO flies. 
 
2.2.4 Embryonic analysis 
 
2.2.4.1 Embryo collection and fixation 
 
Embryos were collected on apple juice - agar plates for 16 h at 25OC. They were dechoronized by 
adding bleach (diluted 1:1 with tap water) to the plates for 1,5 min. After washing away the bleach 
embryos were put into freshly prepared fixation solution (4% formaldehyde, heptan 1:1) and placed 
on rotor wheel for 30 min at 37OC. Next, aqueous phase was removed and 1 vol. of 100% methanol 
was added. After vortexing for 1 min. fixative was removed and embryos were quickly washed 
several times with methanol and store at – 20OC. 
 
2.2.4.2 Immunostaning 
 
Prior to staining procedure methanol was removed from the embryos and replaced by 1xPBST 
(1xPBS, 0.1% Tween 20). After several quick and three long (15 min) washing steps with PBST, 
embryos were incubated for 30 min at RT with blocking solution (1x PBST + 1% BSA). Next 300 
μl of diluted primary antibody was added ( x μl 1o antibody - accordingly to working dilution, 3 μl 
of normal goat serum (NGS), filled up to 300 μl with blocking solution) and embryos were 
incubated overnight at 4OC. Removing of primary antibody was followed by several quick  and 
three 15 min long washes with 1xPBST. Afterwards embryos were incubated with corresponding 
secondary antibody, diluted in 300 μl blocking solution with NGS, for 1-2 hours at RT.  Depending 
on the secondary antibody labelling, the embryos were handle in following way: 
 
Fluorescent labelled antibodies: 
Antibody solution was removed and embryos were washed several times with PBST. Next, they 
were transferred into a drop of Vectashield mounting medium on the microscope slide. Afterwards, 
cover slip was placed on the top and sealed with nail polish.  
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Biotin labelled antibodies: 
After removing the antibody solution embryos were washed with PBST and incubated for 30 min 
with ABC-Mix (Vecta Stain) (solution A and B diluted 1:100 in PBST). Incubation was followed 
by washing step and embryos were transferred to 24-well plates, where after removing of PBST, 
DAB solution was added to develop the signal (DAB diluted 1:5 in PBST + 1 μl of 0,3% H2O2). 
When staining achieved wished strength, reaction was stopped by removing DAB solution and 
washing with PBST. Next embryos were dehydrated by series of 10 min washing in increasing 
ethanol concentrations: 25%, 50%, 75%, 90%, 95% and 100%. The dehydrated embryos were 
transferred into 100% acetone and incubated for 10 min. Subsequently acetone was replaced with 
acetone: araldite solution (1:1) and embryos were transferred into the plastic pot filled partially with 
pure araldite.  Embedded embryos were kept at -20OC. For microscopic observation single embryos 
were transferred form the pot onto microscopic slides.  
 
2.2.5 Immunostaining of third instar larvae. 
 
L3 larvae were filleted open along the ventral midline, dissected in 1x PBS and fixed for 20 min in 
4% paraformaldehyde in PBS at room temperature. After 2- 3 10 minutes long washes in 1xPBT 
(1x PBS + 0.3% TritonX) dissected larvae were incubated for 30 min. in blocking buffer (1xPBTB - 
1x PBT with 1% BSA). Fixed larvae were incubated with primary antibody (diluted in 1xPBTB) 
overnight at 4OC. Prior to incubation with secondary antibody (1.5h, RT) samples were washed 
twice with 1xPBT. Washing step was repeated after removing secondary antibody and larvae were 
mounted in Vectashield mounting medium on the microscope slide. 
 
2.2.6 Survival test 
 
To evaluate lethality phase of the mutants embryos were collected on apple juice – agar plates for 2 
-3 h at 25OC, and were counted after 3 hours. These plates were kept at 25OC and non-hatched 
embryos were counted after 24h and 48h. To determinate the developmental stage of these embryos 
they were covered with Voltalef 3S oil (which makes the chorion transparent).  
 
 
 
 
 
 
 18
Material and Methods 
2.2.7 Mapping of chosen mutants 
 
2.2.7.1 SNP mapping 
 
SNP mapping strategy, described by Berger et al.(2001) is based on sequence polymorphism 
between the strain used for mutagenesis (with FRT proximal insertion) and reference strain  (with 
distal EP insertion – yd2w1118 P{ey-FLP.N}2 P{GMR-lacZ.C(38.1)}TPN1; P{EP}EP511/CyO). The 
mapping strategy can be divided in two steps: obtaining of the set of FRT and EP recombinant 
chromosomes with different break points and mapping of the mutation to the genome region by 
molecular and phenotypic analysis of recombinants. 
 
 
Figure 2.2 Scheme of establishing recombinants stocks. Green line represents FRT chromosome, red EP chromosome, 
black – balancer chromosome.  Triangles represent FRT and EP insertion (green and red respectively). Asterisk – 
mutation. 
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Establishing of recombinants stocks 
Stocks of different recombinants between mutagenised FRT chromosome and reference line were 
established (fig. 2.2). To obtain these stocks, males from mutant line of interest were crossed to 
females from EP line. In next generation females carrying both mutated FRT and EP chromosomes 
were collected and crossed to males from original FRT line. From their progeny, males carrying 
recombinant chromosome were collected. The eye-colour mosaicism was used to identify 
recombinant chromosome with both EP and FRT insertion - due to presence of eyFLP transgene, 
such a chromosome results in mosaic eyes. In the next step single recombinant males were crossed 
to double balancer stock in order to establish stable stocks. 
 
Phenotypic analysis of recombinants 
All recombinant stocks were analysed for presence or absence of mutant phenotype with MARCM 
system as described earlier. 
 
Molecular analysis 
Genomic DNA was isolated for each recombinant stock according to the large scale DNA 
preparation protocol (FlySNP Website, http://flysnp.imp.ac.at). From each line, 1-2 males were 
placed in PCR tubes (0.2ml) and mashed for 5-10 seconds with the tip of a pipet containing 50 μl of 
Squashing Buffer (10mM Tris-HCl pH8.2, 1mM EDTA, 25mM NaCl, 200μg/ml Proteinase K 
(stock 20mg/ml, Quiagen)). Then buffer was expelled from the tip and tubes were placed in 37OC 
for 30 minutes followed by proteinase K inactivation by incubation at 95OC for 5 min. In last step 
50 μl of H2O was added and DNA could be used for PCR reactions. 
Randomly chosen DNAs were analysed in Restriction Fragment Length Polymorphism (RLFP) and 
PCR-product length polymorphism (PLP) assay for different SNP markers (FlySNP Website, 
http://flysnp.imp.ac.at). Used markers and attributed data are listed in tab.2.2 
 
RFLP assay 
PCR mix: 
 2.5 μl   10x RedTaq Buffer without MgCl2 (Sigma) 
 2 μl  10mM dNTPs 
 1.5 μl  MgCl2 (25mM) 
 13.5 μl dH2O 
 0.5 μl  RedTaq Polymerase (1u/ μl) (Sigma) 
 1 μl  primer L (10pmol/ μl) 
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 1 μl  primer R (10pmol/ μl) 
 3 μl  genomic DNA (from 1-2 flies) 
 
PCR programm: 
1. Denaturation  5’ 94OC 
2. Denaturation  30’’ 94OC 
3. Annealing  30’’ 62OC 
4. Extension  2’ 72OC (2 → 4 x 40 cycles) 
5. Extension   5’ 72OC 
6.     ∞ 4OC 
 
5 μl of PCR product was digested with the appropriate restriction enzyme in 20 μl reaction and 
separated on 2.5% agarose gel. 
 
PLP assay 
PCR mix: 
 2.5 μl  10x RedTaq buffer without MgCl2 (Sigma) 
 2 μl  10mM dNTPs 
 3.5 μl  MgCl2 (25mM) 
 14.5 μl dH2O 
 0.5 μl  RedTaq Polymerase (1u/ μl) (Sigma) 
 1 μl  primer L 
 1 μl  primer R 
 1 μl  genomic DNA (from 1-2 flies) 
 
PCR programm: 
1. 5’ 94OC 
2. 30’’ 94OC 
3. 30’’ 60OC 
4. 1’ 72OC (2 → 4 x 40) 
5. 5’ 72OC 
6. ∞ 4OC 
 
8-10 μl of PCR product were loaded on 2.5% agarose gel. 
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Table 2.2 SNP markers used for molecular analysis. Primers sequence and restriction sites information from The 
FLYSNP Database (http://flysnp.imp.ac.at/snpdb.php). 
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Combined information from phenotypic and molecular analysis resulted in placement of the 
mutation between two markers. Having the region of app. 1-2 Mb determined, all recombinants 
were screened for informative crossing over event between these two markers. If possible additional 
marker placed in between was tested to narrow down the region of interests. Recombinants with 
informative crossing over events were analysed further for more markers in these region.  
 
2.2.7.2 Deficiency mapping 
 
Deficiency mapping was based on lethality complementation between mutants and different sets of 
deficiencies. Deficiencies stocks are listed in Appendix (tab.A.1). For each cross 4 to 5 females from 
mutant stock were crossed to 2-3 males from deficiencies stocks. Crosses were kept at 27OC and 
progeny was screened for absence of non-CyO flies, meaning lack of complementation between 
crossed lines. 
 
2.2.7.3 Sequencing of candidate genes 
 
DNA preparation from single embryo. 
Embryos from original FRT line and respective mutant line were collected for 5 hours and fixed as 
described earlier. After fixation methanol was removed and embryos were washed 2x in PBST. 
Mutant embryos were additionally stained for presence of CyO ftz – lacZ chromosome. Single 
homozygous embryos were placed in PCR 0.2 ml tube and 10 μl of homogenizing buffer (10mM 
Tris pH 8.3, 0.5% Tween20, 0.5% NP-40, 50 μlM KCl) with 0.2 μl Proteinase K (20mg/ml, 
Quiagen) were added. Tubes were first kept for 2 hours at -20OC and later for 30 min at 37OC and 3 
min. at 95OC. After gentle mixing of the reaction 1 μl was used for PCR. 
 
Amplification of candidate genes 
For each candidate gene primers were designed with primer3_www.cgi v 0.2 program 
(http://frodo.wi.mit.edu/cgi-bin/primer3/primer3.cgi). From all genes only exons were amplified 
and size of the products varies from 400 – 700 bp. Oligos used for PCR are listed in Appendix 
(tab.A.2). 
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PCR Mix 
5 μl  5x buffer without MgCl2 (Expanded High FidelityPLUS PCR System, Roche) 
1 μl  10mM dNTPs 
1.5 μl  25mM MgCl2
0.3 μl  High Fidelity Polymerase (Expanded High FidelityPLUS PCR System, Roche) 
1 μl  primer 1 
1 μl  primer 2 
1 μl  DNA 
16.7 μl  dH2O 
 
PCR program 
1. 5’ 94OC  
2. 30’’ 94OC 
3. 30’’ 54OC 
4. 1’30’’ 72OC 2 → 4 x 30 
5. 5’ 72OC 
6. ∞ 4OC 
 
5 μl of PCR product were separated on the 1.5% agarose gel to estimate amount of DNA. 
 
Purification and sequencing of PCR product  
PCR products were purified from the solution with GFX PCR DNA gel and solution purification kit 
(Amersham Biosciences) and 1- 6.5 μl  was used for sequencing reaction (depending on DNA 
concentration). Each PCR product was sequenced in both directions with the same primers as used 
for amplification. 
 
Sequencing Mix 
 
2 μl Big Dye Terminator v.3.1 (Perlin Elmer) 
1 μl primer (10pmol) 
1-6.5 μl DNA 
6-0.5 μl dH2O 
10 μl 
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Sequencing program 
 
1. 5’ 96OC 
2. 30’’ 96OC 
3. 15’’ 50OC 
4. 4’ 60OC  2 → 4 25x 
5. ∞ 4OC 
 
The volume of sequencing reaction was made up to 20 μl before the sequencing of amplified 
product, obtained sequences were analysed using Vector NTI software (Invitrogene). 
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3. Results  
 
3.1 MARCM screen 
 
To identify novel genes involved in tracheal morphogenesis we performed a genetic screen, based 
on EMS (Ethyl Methane Sulfonate) mutagenesis. We were interested in late events of tracheal 
formation thus to overcome potential early lethality caused by induced mutations, we applied as a 
screen tool the MARCM system allowing analysis of homozygous mutant clonal cells in 
heterozygous background.  
Previous analysis of clonal cells in trachea of wild type third instar larvae and a pilot screen (see A. 
Bilstein, PhD thesis) led to determination of wild type features and to establishment of screening 
criteria. In larvae with wild type clonal cells, number of clonal cells varied from 30 to 80 per larva. 
They were distributed randomly in all types of branches. Usually the number of clonal cells was 
slightly higher in anterior part of the larva. The clonal cells on the dorsal trunk were large and 
hexagonal, except for fusion cells which had a ring-like shape. Cells on secondary branches were 
elongated and varying in size depending on position. The number and lengths of branches in clonal 
terminal cells were highly variable with higher branching rate in the anterior part of the animal. A 
properly formed lumen filled with gas can be found in all clonal cells. Additionally, due to 
breathless expression in the epidermis, a number of GFP positive epidermis cells could be 
observed. Also two GFP marked cells were often found in the heart. 
After inducing mutations with EMS in males we set up approximately 6000 single crosses and were 
able to establish 4779 stocks carrying mutated chromosomes. The loss of lines occurred at two steps 
of the procedure. 16% of single crosses did not give any progeny and 6% did not survive the heat-
shock. We screened 4779 mutated lines analyzing the number, size, shape and distribution of clonal 
cells. Also the shape and formation of the lumen within clonal cells were taken into account. We 
observed the wild type phenotype in 4452 lines, whereas in 344 we detected defects in one or more 
of the analysed criteria. We classified the mutations into the five phenotypic groups as listed in 
table 3.1 and described in detail below. Five mutations showed phenotypes that did not fall into any 
of the proposed phenotypic classes. These were: 
• 2L0419 – mutant tracheal histoblasts were smaller; line was homozygous lethal  
• 2L0445 - abnormally shaped and too small clonal cells in the dorsal trunk and secondary 
branches (e.g. transverse connective); line was homozygous viable 
• 2L1281, 2L1296 – clonal cells absent in the epidermis; 2L1281 was homozygous lethal, 
2L1296 viable; 
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• 2L3574 – clonal cells present only in the epidermis but not in the trachea; line was 
homozygous lethal. 
All mutant lines are listed in table A3 (Appendix). 
 
 
GROUP 
  
PHENOTYPE 
 
NO of 
LINES 
 
SUB- 
GROUP 
 
SUBGROUP 
PHENOTYPE 
NO of 
LINES (in 
subgroup) 
A no clones - cell 
lethal mutations 
163 - 
 
- - 
0 low number 11 B low number of 
clonal cells 
20 
I extremely low number 9 
0 small clonal cells 20 
I extremely small clonal 
cells 
7 
C small clonal cells 47 
II low number and small 
clonal cells 
20 
0 not sub-classified  6 
I DT bendings 10 
II clonal cells only in DT 4 
III small clonal cells in DT 5 
D dorsal trunk  28 
IV low no / no clonal cells in 
DT 
3 
0 not sub-classified 10 
I TB crossing/fusion 24 
II less or no branches 11 
III problems with lumen 
formation 
19 
IV expanded/elongated TB 4 
E terminal branching  81 
V no/less clones in TB 13 
 
Table 3.1. Classification of identified mutants. Additionally, 5 lines showed phenotypes that did fall into any of these groups (see above). (DT – 
dorsal trunk, TB – terminal branches) 
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3.2 Phenotypic classes 
 
The phenotypes observed in the mutants of the five phenotypic classes are described in detail in the 
following sections. 
 
3.2.1 Group A – no clones 
 
The phenotype characteristic for this class was the absence of clonal cells. This was the largest 
group, consisting of 163 lines. The class was not analysed any further. 
 
3.2.2 Group B - low number of clonal cells  
 
The 20 lines classified into group B displayed a reduced number of clonal cells (fig. 3.1). We 
observed two phenotypic subgroups; one with number of clonal cells varying from 10 to 30 per 
larva (10 lines –subgroup B 0, low number) and one with less than 10 clonal cells per larva (10 lines 
- subgroup B I, extremely low number).  
 
 
Figure 3.1. The phenotypes of group B – low number of clonal cells. Dorsal trunk of wt (A) and two mutant lines (B 
and C). Lines classified into this group were divided into two sub-groups: with clone number between 10 and 30 (B 0 –
B) and below 10 (B I – C) Arrowheads indicate clones in transverse connectives. 
 
3.2.3 Group C – small clonal cells 
 
Group C consists of 47 lines with clonal cells of reduced size (fig 3.2). Here we also distinguished 
more than one type of defect. In 7 lines the size reduction was very strong (subgroup C I, extremely 
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small clonal cells) and in 20 lines the small size of the clonal cells was combined with their low 
number (subgroup C II, low number and small clonal cells). In addition to reduced size clonal cells 
often had irregular shapes, especially in the dorsal trunk (fig. 3.2 C). 
 
 
Figure 3.2. The phenotypes of group C – small clonal cells. Dorsal trunk with wt (A) and mutant (B-D) clonal cells 
(arrowheads). Lines representing three sub-groups are shown, B – small clonal cells (C 0), C – extremely small clonal 
cells (C I) and D – low number and small clonal cells (C II). Clonal cells in the mutant line in C did not show the 
hexagonal shape typical for wild type dorsal trunk cells. 
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3.2.4 Group D – dorsal trunk defects 
 
The 28 lines from group D showed defects in the dorsal trunk (DT). We classified them into five 
subgroups.   
 
The first – D 0 - consists of 6 lines with defects not observed in any other subgroup. 
• 2L0128 – clonal cells in DT larger than wild type (fig 3.3 B) 
• 2L0196 - DT narrowed within clonal cell 
• 2L0372 – smaller lumen and irregular shape of clonal cells in DT 
• 2L3090 – rounded and smaller clonal cells in DT and secondary branches (fig 3.3 D) 
• 2L3191 – irregular lumen in DT at clonal position 
• 2L4771 – bendings in fusion cells of DT if clonal, no clonal cells in terminal branches and 
no clonal cells in other fusion cells 
 
 
Figure 3.3 Phenotypes of group D 0. In line 2L0128 (B) clonal cells on dorsal trunk (DT) - arrowhead - are larger than 
in wt (A). Clonal cell in dorsal trunk and transverse connective (TC) of line 2L3090 (D, white arrow DT, red TC) are 
smaller and rounded up comparing to wt (C). 
 
The second subgroup – (D I – dorsal trunk bending) consists of 10 lines. They exhibited bendings 
of the dorsal trunk at the position of clonal cell (fig.3.4) whereas other branches were unaffected.  
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Figure 3.4 Group D I – DT bendings – in the mutant (B) dorsal trunk bends at position of clonal cells (arrowheads) what 
is not observed in wild type (A) 
 
In four lines belonging to subgroup D II clonal cells were present only in the dorsal trunk (data not 
shown).  
 
The subgroup D III consisting of five lines had small clonal cells in the dorsal trunk (fig. 3.5). The 
defect in the size of clonal cell was restricted to the dorsal trunk. The clonal cells on other branches 
were like in wild type.  
 
 
Figure. 3.5 Group D III – small clonal cells in DT. Clonal cells in DT (arrows) of mutant line (B) are reduce in size 
comparing to wt (A) 
 
The last subgroup, D IV (low number/no clonal cells in the dorsal trunk; data not shown), was 
characterized by a low number or complete lack of clonal cells in the dorsal trunk and harboured 
three lines. 
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3.2.5 Group E – terminal branching phenotypes 
 
The last class, consisting of 81 lines with terminal branching phenotypes, was divided into six 
subgroups.  
 
The subgroup E 0 includes 10 lines with complex defects. 
• abnormal formation of terminal branches (2L1668, 2L1923, 2L2806, 2L3047, 2L3193, 
2L3393; fig. 3.6, B-D) 
• larger diameter of terminal branches (2L2084, 2L2944, 2L3807; not shown) 
• smaller diameter of terminal branches (2L4105, 2L4515; fig 3.6 E) 
• abnormal ratio of clonal cells in terminal branches and other types of branches (2L4155, 
2L3807; not shown) 
• fewer branches in terminal cells (2L4155, 2L2944; fig 3.6 F) 
• no lumen in terminal branches (2L4155; fig 3.6 F) 
 
The subgroup E I (terminal branches crossing/fusion) is characterized by ‘terminal branch crossing’ 
(fig. 3.7). Two types of this defect can be distinguished: crossing of branches of single terminal cell 
and crossing of branches of two different cells. As shown in fig.3.7 A-B, in wild type the branches 
of neighbouring terminal cells, even if growing into the same region of tissue, never crossed the 
‘border’ present between them and thus did not cross each other. In mutants such a restriction was 
not observed. Also the phenomenon of ‘crossing’ or fusion between branches of single terminal cell 
found in these mutants (fig. 3.7 C-F) did not occur in the wild type larvae. We identified 24 lines 
with such a phenotype.   
 
The subgroup E II (less or no branches) consists of eleven lines exhibiting reduced or completely 
absent branching of terminal cells. The strength of this phenotype differs between the lines as 
depicted in fig 3.8. In some lines terminal cell formed a proper tree, but the cytoplasmic extensions 
were shorter (fig 3.8 B). In other branching did not occur at all (fig 3.8 C) or was strongly reduced 
(fig 3.8 D). Finally, in a few lines branching stopped after the first ramification (fig 3.8 E and F). 
 
In four lines from subgroup E IV (expanded/elongated terminal branches) the opposite phenotype - 
excessive branching - was observed. Lines from this subgroup are shown in fig 3.9. In all lines, 
terminal cells were strongly ramified compared to wild type cells at similar positions (dorsal 
terminal cells). 
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Figure 3.6 Phenotypes of group E 0. A – wt terminal clonal cell – branches were growing in all direction and formed 
extended trees. Gas filled lumen could be visible (arrow). B-D – different examples of abnormal TB formation. E – 
diameter of the lumen was smaller than in wt (arrow). F – no gas filled lumen could be seen in terminal cell (arrow), 
very few branches could be found. 
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Figure 3.7 Phenotypes of group E I –‘terminal branches crossing/fusion’. In wt (A) two neighbouring terminal cells 
populating the same region of target tissue do not cross each other and do not cross  ‘border’ between their regions 
(dotted line). Also branches of individual cell do not cross each other or fuse.  In mutant lines neighbouring cells cross 
‘the border’ (dotted line in B) and branches of other cells (C, arrow). Also within single cell ‘crossing’ can be observed 
(arrow in D and F). Additionally in few lines (i.e. 2L2445) branches fuse (E, arrowhead) 
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Figure 3.8 Phenotypes of group E II – less or no branches. A - wt terminal cell. B-F - examples of mutant cells with 
different strength of phenotype. B – weak  - tree is properly formed but branches are shorter; C – strong – branching 
almost completely abolished; D – branching strongly reduced; E-F – mild – branching stops after first ramification. 
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Fig. 3.9 Group E IV – expanded terminal branches. Dorsal branches of mutant lines (B-D) are more ramified than the 
wt (A) 
 
The subgroup E III exhibited problems with lumen formation within the terminal branches. The 
strongest phenotype in this group was a complete abolition of lumen formation within the branch as 
depicted in fig. 3.10 G-H (6 lines). Also milder phenotypes with partially formed lumen were found 
(10 lines fig 3.10 C-D).  In three cases we observed properly formed but mispositioned lumen. In 
the wild type, the lumen was placed centrally in the cell whereas in these lines it was on the side 
and in one case lumen seemed to ‘turn back’ within the cell (fig. 3.10 E-F). Most of the 19 lines 
showed reduced number and length of branches. Additionally two lines were lacking lumen in 
clonal cells in secondary branches.  
 
The subgroup E V, the last class with terminal branching defects, consists of 13 lines in which no 
clones could be observed in terminal cells or their number was strongly reduced in comparison to 
the number of clones in other branches (data not shown).  
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Figure 3.10 Group E III – lumen formation problems. Right panel: – GFP; left panel:  bright field images of the same 
cells. A- wild type terminal cell of dorsal branch. White arrow indicates presence of gas filled lumen, red arrowhead 
shows centrally placed lumen within the cell. In line 2L3340 (C-D) terminal cells do branch, but gas filled lumen is 
only partially formed (arrows). White arrowheads in E and F mark branch ‘turning back’ within the cell. The lumen of 
this cell is misplaced to the lateral side of the branch (red arrowhead). G and H: complete abolishment of lumen 
formation within clonal cell (arrow). 
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3.3 Complementation test 
 
To evaluate if any of the observed phenotypes are caused by mutations in the same gene we 
performed complementation tests. Phenotypes of mutant lines can be observed only in clonal 
analysis which requires crossing in the MARCM system components. Thus it was impossible to 
complement the phenotypes of different lines. Hence we decided to complement mutant lines for 
lethality.  
First we checked all the lines except the ‘no clones’ group if they were homozygous lethal or not. 
We found 78% of lines from groups B-E to be homozygous lethal. We tested these lines within each 
phenotypic group for absence of complementation. We did not cross lines from different groups, 
except for subgroup C II (low number and small clonal cells) and group B. 
 
No of lines Group 
In 
total 
lethals 
Lethality 
% 
No of 
comple
mentati
on 
groups 
Complementation 
groups 
Group members No of 
single 
hits 
A 163 - - - - - - 
B1 2L4332/2L4449 B 20 13 65 2 
B/C1 2L3456(CII)/2L4332 
10 
C1 2L2416/2L2648/2L3301 
C2 2L3301/2L3918/2L3937 
C3 2L4081/2L1749/2L2953 
C4 2L4081/2L2816 
C5 2L2816/2L3547 
C6 2L3311/2L3500/2L3908 
C7 2L3908/2L3642 
C8 2L1663/2L3642/2L3390 
C9 2L1663/2L2572 
C10 2L1554/2L2572 
C11 2L1554/2L2269 
C12 2L2269/2L2526 
C13 2L3569/2L3948 
C14 2L1360/2L4774 
C15 2L0944/2L3651/2L4508 
C 47 41 87.2% 16 
C16 2L4508/2L3456 
14 
D1 
 
2L0439/2L1506/2L1687
2L2181/2L3179/ 
2L3696/2L3910/2L4333 
D2 2L0028/2L1693/2L3707 
D 28 24 85.7 3 
D3 2L2676/2L2769/2L3090 
10 
E1 2L1923/2L3244 
E2 2L3637/2L4501 
E 81 58 71.6 3 
E3 2L2218/2L3443 
52 
 
Table 3.2: Results of complementation test. 
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In total we have identified 24 complementation groups (tab. 3.2): 
Group B: 2 groups with 2 members each; 
Group C: 16 groups: 6 with 3 members each and 10 with 2 members each; 
Group D: 3 groups: 1 with 8 members and 2 with 3 members; 
Group E: 3 groups with 2 members each;  
The eight lines from group C belong to more than one complementation group. In case of one group 
from class D (D3) all three lines not complementing each other show different phenotypes. 
 
3.3.1 Complementation test for ‘no clones’ class  
 
When we analysed lines identified in the pilot screen for defects in the development of embryonic 
trachea (A. Bilstien, PhD thesis) we observed slightly convoluted dorsal trunks in line 2L0058, a 
member of the ‘no clones’ class  (fig 3.11 C). This phenotype is characteristic for mutations in 
genes involved in control of tube size and diameter (reviewed in Wu and Beitel, 2004). There are 
three known genes on the left arm of the second chromosome showing such defects when mutated: 
varicose (vari), convoluted and nrv2, and there was a possibility that line 2L0058 carried a mutation 
in one of these genes. To test this we checked line 2L0058 for complementation of lethal alleles of 
these three genes and found it to complement all three. However, the observation that a line 
showing no clones in MARCM system exhibited convolution of dorsal trunk in the embryo 
indicated that other lines from the ‘no clones’ class might also have such a phenotype and be allelic 
to one of genes mentioned above. Thus we performed complementation tests between all ‘no 
clones’ lines and 2L0058, vari and convoluted. Nrv2 has not been tested due to stock contamination. 
Two complementation groups were identified: 
A1) 2L0058, 2L1963, 2L3002, 2L3794, 2L4745 and 2L3215; 
A2) vari, 2L1623 and 2L3215; 
Line 2L3215 did not complement members of either. 
Lines from group A1, except for 2L0058, did not show any defect in embryonic trachea. Both lines 
from group A2 exhibit the vari phenotype (fig.3.11), although the phenotype in line 2L3215 seemed 
to be weaker. 
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Figure 3.11 Embryonic trachea in homozygous embryos (stage 15/16) visualised by luminal marker 2A12. A – wt 
embryo, B,D-E embryos from complementation group A2, C – embryo from line 2L0058. All mutant lines show dorsal 
trunk convolution  phenotype. Anterior to the left, dorsal up. 
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3.4 Analysis and mapping of selected candidate lines. 
 
After the preliminary description of mutant lines the next steps was the characterisation of observed 
phenotypes in detail and mapping of the mutation. However, handling all lines simultaneously was 
difficult. So I decided to concentrate on three groups of lines. Selection criteria were high number 
of alleles or interesting phenotype. The first criterion was fulfilled by complementation group D1. 
The eight lines from this group showed defects in the dorsal trunk. Additionally I found defects in 
lumen formation in terminal branching very interesting and thus analysed further two 
complementation groups found within this phenotypic class. These were E2 and E3, consisting of 
two lines each. Details of analysis and mapping on all three groups are presented in next sections.  
 
3.4.1 Group D1-analysis and mapping. 
 
The group D1 consists of eight lines from class D I – dorsal trunk bendings. They did not 
complement each other, showed the same phenotype and thus could be considered as allelic. These 
were: 2L0439, 2L1506, 2L1687, 2L2181, 2L3179, 2L3910, 2L3696 and 2L4333.  
 
3.4.1.1 Phenotype description and analysis 
 
As described in section 3.2.3, in these lines the dorsal trunk bended at the position of the clonal cell. 
The strength of the bending differed between the mutants (fig. 3.12). The weakest defect was 
observed in lines 2L3179 and 2L4333 (fig. 3.12 D and F) and the strongest in lines 2L1506 and 
2L3696 (fig. 3.12 B and I). Additionally clonal cells in the dorsal trunk looked smaller than wild 
type clonal cells and their shape was irregular. The total numbers of clonal cells as well as the 
average amount of clonal cells in the dorsal trunk were not affected in mutant larvae (tab. 3.3). 
The observed phenotype was not fully penetrant. The lowest number of clonal cells showing the 
defect (55.87%) was found in line 2L3696 and highest in line 2L4333 (80%; tab. 3.3). Interestingly 
line 2L3696 showed very strong bendings, whereas defect in line 2L4333 was weak. However such 
correlation could be only found for these two lines.  
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Clones in DT Line Counted 
larvae 
Counted 
clones 
Average 
clone no 
per larvae In 
total
average per 
larvae 
DT clones 
with 
phenotype 
% of clones 
showing 
defect 
FRT40A 15 455 30.3 ± 8.8 191 12.7 ± 5.5 0 0% 
2L0439 12 322 27.7 ± 8.9 130 10.8 ± 3.2 86 68% 
2L1506 15 356 23.7 ± 6.7 144 9.6 ± 3.2 103 72% 
2L1687 17 472 27.8 ± 9.1 212 12.5 ± 6.5 149 71.82% 
2L2181 15 469 31.3 ± 8.7 186 12.4 ± 8.4 125 72% 
2L3179 10 276 27.6 ± 6.3 118 11.8 ± 4.2 94 78.88% 
2L3696 10 274 27.4 ± 10.9 82 8.2 ± 4.7 44 55.87% 
2L3910 19 542 28.5 ± 10.4 198 10.4 ± 5.1 146 72% 
2L4333 14 480 34.3 ± 10.1 195 11.1 ± 3.7 155 80% 
Tabel 3.3 Numbers of clonal cells in the alleles from group D1 and phenotypic penetrance.  
 
 
Figure 3.12. Group D1. In all 8 lines (B-I) DT bends at clonal cell position (white arrowheads), what is not observed in 
wt clonal cells (A). The strength of the bending varies between the mutant lines. Lines 2L3179 (D) and 2L4333 (F) 
exhibit weakest defect (red arrowheads) whereas lines 2L1506 (B) and 2L3696 (I) strongest (green arrowheads). 
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In order to analyse clonal cells and the surrounding cells in more detail staining for armadillo (arm), 
Drosophila β-catenin, was performed. Arm is a component of adherens junctions which localises 
apically in the cells and is involved in cell adhesion (Lecuit, 2005). Thus it is a useful marker for 
both apical membranes and junctions. If cell to cell contact of mutant clonal cell should be affected 
due to defects in adherens junction/cell adhesion, one could expect changes in arm localisation. 
Also any changes in cell shape or size should be revealed by arm staining. In the mutant clonal cells 
no difference in arm localisation was observed (fig. 3.13), but labelling of cell membranes 
confirmed a reduction in the size of clonal cells as well as their abnormal shape.  As depicted in fig 
3.13 D-I, clonal cell were much smaller than neighbouring cells and they lost hexagonal shape 
typical for cells in dorsal trunk. 
 
 
Figure 3.13 Armadillo staining in the DT of larvae with wt (A-C) and mutant (D-I) clones. In wt clonal cells no 
difference between clonal (white arrowheads) and neighbouring cells could be observed. In the mutant, clonal cells 
were smaller than neighbouring wild type cells (yellow arrowheads) and irregular in shape. 
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3.4.1.2 Analysis of embryonic phenotype 
 
For most of the genes known to be involved in tracheal development embryonic phenotypes have 
been described. So it was interesting to analyse if the alleles from group D1 showed any defect in 
the development of embryonic trachea when homozygous. That being the case, comparison of 
observed phenotype with defects in mutants of known genes could help in identification of the gene 
responsible for clonal phenotype. 
The embryonic tracheal development was examined in all eight alleles. To distinguish mutant 
homozygous embryos from heterozygous or CyO homozygotes, CyO chromosome with ftz-LacZ 
insertion was used. This insertion leads to expression of β-Galactosidase in the pattern of fushi 
tarazu in the embryos carrying CyO chromosome. By anti-β-Gal staining mutant homozygous 
embryos could be thus identified. Staining for luminal marker 2A12 revealed that all but one line 
showed wild type tracheae. In line 2L0439 breaks in the dorsal trunk were observed. As can be seen 
in fig. 3.14, lumen in the dorsal trunk stayed discontinuous throughout development. In few 
embryos a milder phenotype showing just narrowed lumen was also found (fig.3.14 F).  
Next tracheal cells of mutant embryos were marked with UAS-β spectrin-GFP expressed under 
control of btl-GAL4 driver in order to verify if absence of 2A12 staining was due to break of the 
trunk or lack of the lumen. If observed breaks were caused by absence of the lumen, α-GFP 
antibody staining should showed the intact dorsal trunk and breaks in the α-2A12 staining. If gaps 
were due to breaks of the dorsal trunk then they should been also obvious by GFP staining. The 
double staining for GFP and 2A12 revealed that the second scenario is more likely because gaps in 
luminal staining were accompanied by strong reduction of diameter of surrounding tracheal cells 
(fig 3.15). The presence of defects in the embryonic tracheae in only one line suggests it is caused 
by additional mutation on second chromosome in line 2L0439 and the phenotype is not related to 
defect observed in clonal analysis in larvae. 
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Figure 3.14 Embryonic trachea marked by luminal (2A12) staining of wt (A, C, E) and 2L0439 homozygous embryos 
(B, D, F). In mutant embryos lumen in DT is discontinuous both in early (st. 14, B) and later (st 16, D) stages (black 
arrowheads). In some embryos, although no breaks were found, diameter of the lumen was strongly reduced (F red 
arrowheads, insert show magnification of region marked by rectangle). Lateral view, anterior to the left, dorsal up. 
 
 
 
 
 
 
Figure 3.15  Wt and 2L0439 embryos with GFP labelled tracheal cells  (A,C) stained for luminal marker 2A12 (B,D). In 
mutant embryos break in 2A12 staining (insert in D, arrowhead) is accompanied by reduction in diameter of DT (insert 
in C, arrowhead). Lateral view, anterior to the left, dorsal up. 
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3.4.1.3 Survival test 
 
The next question to ask was at what stage the analysed mutations cause lethality.  Hence a survival 
test was performed. First, lethality stage of CyO/CyO animals had to be determined. It is known 
that original CyO balancer leads to larval lethality if homozygous. However chromosome used to 
balance the mutations has additionally ftz-LacZ insertion and it was not clear if animals 
heterozygous for this balancer hatch. Thus embryos from FRT40A/ CyOftz LacZ flies were analysed 
for survival and consider later as a wild type reference. Embryos were collected and left to develop. 
After 24 and 48 hours non-hatched embryos were counted. 25% of reference embryos did not hatch, 
which suggests that CyOftz LacZ chromosome is embryonic lethal if homozygous. 
After establishing the controls, embryos from each mutant line were tested as described above.  If 
mutations in lines of interest were embryonic lethal 50% of embryos would be expected to hatch. It 
was the case only for lines 2L0439 and 2L3179 (tab. 3.4). In two lines, 2L2181 and 2L3910, around 
40% of embryos did not hatch. The last four lines 2L1506, 2L1687, 2L3696 and 2L4333 seemed 
not to be embryonic lethal. In all lines a delay in development could be observed (compare number 
of non-hatched embryos after 24 and 48h in tab. 3.4). 
 
Line no Counted 
embryos 
Non-
hatched 
embryos 
after 24h 
Non-
hatched 
embryos 
after 48h 
Expected no of 
CyO/CyO or 
mutation/mutation 
embryos (25%) 
% of non-
hatched 
embryos 
FRT40A/CyO 187 54 46 47 25% 
2L0439 173 91 85 43 49% 
2L1506 158 64 47 39 30% 
2L1687 154 60 39 38 25% 
2L2181 132 82 57 33 43% 
2L3179 167 93 90 42 54% 
2L3696 172 74 55 43 32% 
2L3910 104 68 42 26 40% 
2L4333 141 44 20  35 14% 
 
Table 3.4 Survival test summary. 
 
3.4.1.4 Mapping of complementation group D1 
 
The eight lines showing the same phenotype and not complementing each others lethality suggests 
that mutation causing the phenotype is also the cause for lethality. Thus mapping of lethality should 
lead to identification of the gene responsible for the phenotype. Therefore the lethality based 
deficiency mapping was chosen to map the observed phenotype. Two members of the group were 
crossed to set of deficiencies covering left arm of the second chromosome (stocks listed in 
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Appendix, table A.1 B - Bloomington Dfs kit). The progeny from these crosses was checked for 
lethality complementation. Both analysed lines did not complement deficiency Df(2L)spd[j2] which 
deletes fragment of the chromosome corresponding to region 27C1-2; 28A. To confirm this result, 
remaining members of the D1 group were crossed to this deficiency, and none complemented. By 
using smaller deficiencies, partially overlapping with Df(2L)spd[j2], depicted in fig 3.16, the region 
of the mutation was narrowed down to two intervals of 57kb (A) and  141kb (B). Eighteen genes 
are predicted in these regions. They are listed together with predicted function in table 3.5. 
 
 
Figure 3.16 Deficiency fine mapping for members of DT bendings complementation group. Solid lines represent 
undeleted fragments, dashed lines – unclear regions, deleted fragments are shown as blank. Green indicates 
complementation, red – non-complementation. Horizontal blue dashed lines mark regions A and B uncovered by tested 
deficiency to which mutation maps. In genomic region representation (FlyBase-http://flybase.bio.indiana.edu) cytologic 
regions and genes (in blue) are depicted. 
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Region Gene Function 
A CG10805 unknown 
A CG10806 sodium-hydrogen antiporter, regulation of pH 
A neuroligin Receptor binding protein, involved in development of ectoderm and 
nervous system 
A CG13773 DNA-directed RNA polymerase activity, involved in transcription 
A CG10354 5’-3’ exoribonuclease activity, DNA meatbolism 
B CG31908 unknown 
B CG3476 carnitine transporter activity, lipid metaboslim 
B Rab30 GTPase activity, endocytosis/exocytosis/intracellular transport/small 
GTPases mediated signal transduction 
B CG11266 spliceosome complex  
B milton kinesin-associated mitochondrial adaptor, axon transport of 
mitochondrion 
B  CG31630 unknown 
B Mnn1 GTPase activity, JNK cascade 
B CG31907 Calponin – like actin binding protein, localised to microtubule 
cytoskeleton 
B CG13779 peptidase activity, proteosome complex 
B CG8902 GTPase activity, immune response 
B CG11289 ATPase activity/glucuronosyltransferase activity, defence 
response/polysaccharide metabolism 
B Pvf2 PDGF and VEGF related factor 2, hemocyte migration, proliferation 
B Pvf3 PDGF and VEGF related factor 3, hemocyte migration 
 
Tabel 3.5 Genes in the region to which mutation in D1 group maps. All information about function is adapted from 
FlyBase (http://flybase.bio.indiana.edu). 
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3.4.2 Group E2 - analysis and mapping 
 
Group E2 was chosen for further analysis due to interesting phenotype – defects in lumen formation 
in terminal branches (class E III). It consists of two lines 2L3637 and 2L4501 which show similar 
phenotype and do not complement each other.  
 
3.4.2.1 Phenotype analysis 
 
As mentioned before, in wild type terminal cells the lumen can be visualised by bright filed 
microscopy since it is filled with gas.  In most clonal terminal cells in these lines no gas filled 
lumen could be observed (fig 3.17). There were also few cells with single branches partially filled 
with gas (data not shown) but no terminal branches completely filled with gas could be seen (tab. 
3.6) Additionally gas filling or lumen formation defects were found in clonal cells on secondary 
branches in which the lumen is made by single cell. As depicted in fig 3.18, there were gaps in gas 
filling within clonal cells. They spread across whole lengths of the cell (fig. 3.18 D-F) or just part of 
it (G-H) and the phenotype was not fully penetrant (tab. 3.7). Clonal cells in DT or transverse 
connectives were like wild type.  
 
Clones in TB Line Counted 
larvae 
Counted 
clones 
Average clone 
no per larvae In total Av. Per 
larvae 
TB with 
phenotype 
% of clones 
showing defect
FRT40A 16 493 30.8 ±11.9 82 4 ±3.1 0 0% 
2L3637 26 628 24.2 ± 10.7 86 3.4 ± 1.6 86 100% 
2L4501 24 638 26.6 ± 9.7 68 2.8 ± 1.7 67 99% 
 
Table 3.6 Penetrance of phenotype in terminal branches. 
 
Clones in secondary 
branches 
Line Counted 
larvae 
Counted 
clones 
Average clone 
no per larvae 
In total Av. per 
larvae 
Clones in 
secondary 
branches 
with 
phenotype 
% of clones 
showing defect
FRT40A 16 493 30.8 ± 11.9 82 5.1 ±4.8 0 0% 
2L3637 26 628 24.2 ± 10.7 103 4 ± 2.5 69 74% 
2L4501 24 638 26.6 ± 9.7 77 3.2 ± 2.1 56 70% 
 
Table 3.7 Pentrance of secondary branch phenotype. 
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Figure 3.17 Lumen of terminal branches in lines 2L3637 and 2L4501 is not filled with gas. In wt (A, B), lumen of TB 
can be visualised in bright filed because of gas filling (blue arrow). In both mutant lines no gas filled lumen could be 
observed. Left panel: GFP channel, right panel: bright field image of the same terminal cells. 
 
To study whether gaps in clonal cells were due to absence of lumen or lack of gas filling, I decided 
to analyse the membranes of clonal cells. If the lumen was formed in these cells outer basal and 
inner apical membranes should be detectable. If clonal cells failed to form the lumen only outer 
basal membrane would be present. In order to test this, chromosome with membrane targeted RFP 
(UAS-myrRFP) was crossed into the mutant so that clones would be marked with cytoplasmic GFP 
and membrane localised RFP. If the lumen in clonal cell was formed but not filled with gas no 
difference in RFP localisation between wild type and mutant clones should be found. If gaps were 
caused by the absence of the lumen such a difference should be observed.  As depicted in fig 3.19, 
localisation of myr-RFP differed in wild type and mutant clonal cells on secondary branches at the 
positions where no gas filled lumen was visible in bright field view. In gaps in both mutant lines the 
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GFP and RFP signals were even whereas in parts of clonal cells with lumen as well as wild type 
clones, the signal was absent in the lumen. In few cases the lumen was detectable by absence of 
GFP and RFP signal, but no gas filling could be observed (fig 3.19 I-L and 3.20 I-L). Also in 
terminal branches the absence of lumen was confirmed (fig 3.20).  
 
 
Figure 3.18 Clonal cells in secondary branches of wild type (A-C) and mutant lines (D-I). Lumen in mutant clonal cells 
is absent or unfilled with gas (red arrowheads) 
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Figure 3.19 Clonal cells on secondary branches in wt (A-D) and mutant (E-L), marked with cytoplasmic GFP and 
myrRFP.  In wt and part of the mutant cell in which lumen is still present, signal is absent in middle of the cell (white 
arrowheads), whereas in parts missing the gas filled lumen no gaps in signal could be observed (white arrows).  Yellow 
arrowheads indicate part of the cell in which GFP and RFP signal is absent in the middle of the cell, although no gas 
filled lumen could be seen in bright field. 
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Figure 3.20 Clonal cells in terminal branches in wt (A-D) and mutant (E-L), marked with cytoplasmic GFP and 
myrRFP.  In wt and in part of the mutant cell in which lumen is still present, signal is absent in middle of the cell (white 
arrows), whereas in parts missing the gas filled lumen no gaps in signal could be observed (red arrows). Yellow 
arrowheads indicate part of the cell in which GFP and RFP signal is absent in the middle of the cell, although no gas 
filled lumen could be seen in bright field. 
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3.4.2.2 Analysis of embryonic phenotype 
 
The fact that gaps in lumen in clonal cells on secondary branches were not always spanning the 
entire cell length suggested that mutant cells are able to form the lumen. In order to confirm, that in 
mutant lines formation of a lumen made by a single cell is possible, homozygous embryos from 
both lines were stained for the luminal marker - 2A12. The absence of staining in dorsal branches or 
lateral trunk would suggest that formation of the lumen by single cells is impaired. No such defects 
were found (fig 3.21), thus the lumen in the embryonic trachea is formed normally.  
 
 
 
 
Figure 3.21 Embryonic tracheae stained with luminal marker 2A12 in wild type (A, B) and 2L4501 homozygous 
embryos (C, D). No defects in lumen formation were found. Embryos stage 15/16 A, C lateral view, anterior to the left 
dorsal up; B, D dorsal view, anterior to the left. 
 
 
3.4.2.3 Survival test 
 
To determine at what stage mutations induced lethality, survival test was performed. Embryos from 
both lines were collected and left to develop. Non-hatched embryos were counted after 24 and 48 
hours. As mentioned in section 3.4.1.3, CyOftz-LacZ homozygous animals die as embryo. Table 3.8 
shows that 34.1% of 2L3637 and 54.6% of 2L4501 embryos did not hatch. It indicates that mutation 
in line 2L4501 is embryonic lethal whereas line 2L3637 is semi-lethal and some embryos develop 
to the larval stages. 
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Line Counted 
embryos 
Non-
hatched 
embryos 
after 24h 
Non-
hatched 
embryos 
after 48h 
Expected no of 
CyO/CyO or 
mutation/mutation 
embryos (25%) 
% of non-
hatched 
embryos 
FRT40A/CyO 187 54 46  46-47 24.6% 
2L3637 454 169 155 113 34.1% 
2L4501 237 130 120 59 54.6% 
 
Table 3.8 Survival test for lines 2L3637 and 2L4501, FRT40A/CyO flies were used as a reference to determine the 
number of homozygous CyO embryos that do not hatch. 
 
 
3.4.2.4 Mapping of group E2 
 
Although this group consists only of two lines, mapping approach based on complementation of 
lethality by set of deficiencies was chosen. The observed phenotypes of both lines are very likely to 
be lethal. Additionally probability that two different genes are mutated in both lines is rather low. 
Thus mapping of lethality should lead to identification of the gene responsible for observed 
phenotypes. 
Both lines were crossed to set of deficiencies covering left arm of second chromosome. These 
deficiencies, established by Exelixis Inc., have moleculary mapped break-point what makes them 
more accurate for mapping (stocks listed in Appendix table A.1 C Exelixis Df Kit). The progeny 
from the crosses were screened for lethality complementation. Both lines complemented lethality of 
all deficiencies, which indicates that mutation causing the phenotype is in the gene uncovered by 
this set. 
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3.4.3 Group E3 –analysis and mapping 
 
Group E3 was chosen for further analysis also due to interesting phenotype and because it consists 
of two lines, 2L2218 and 2L3443 non-complementing the lethality. They were classified to 
subgroup E III and show defects with lumen formation.  
 
3.4.3.1 Analysis of the phenotype 
 
In both lines the lumen in terminal branches was partially or completely absent. Additionally, in 
line 2L2218 number of clonal cells was strongly reduced and very few larvae with clonal cells 
could be found. Due to difficulties in obtaining larvae with clones in the line 2L2218 as well as 
sickness of this stock, most of the analysis were performed only with line 2L3443. 
As depicted in fig 3.22, the strength of the phenotype differed between the larvae and also between 
the branches in one animal. In some terminal cells part of the cellular extension still had a gas filled 
lumen (fig. 3.22, C,D) whereas in others the lumen was present only in the non-ramified part of the 
cell close to a neighbouring secondary cell (E,F) and finally in some it was completely absent in 
terminal cells (G,H). Independent of the presence or absence of lumen in these cells the number of 
branches was reduced in all. However only ~ 50% of terminal cells in line 2L3443 showed the 
phenotype (tab. 3.9). The penetrance of the phenotype in line 2L2218 could not be evaluated due to 
low number of analysed larvae. 
 
Clones in TB Line Counted 
larvae 
Counted 
clones 
Average clone 
no per larvae In total Av.  per 
larvae 
TB with 
phenotype 
% of clones 
showing defect 
TB170 16 435 27.2 ± 10 67 4.2 ± 2.7 0 0% 
2L3443 34 615 18.5 ± 7.7 124 3.9 ± 1.8 63 51% 
2L2218 2 8 4 ± 0 5 2.5 ± 0.7 5 100% 
 
Table 3.9 Penetrance of the phenotype in E3 complementation group. The low number of analysed larvae in line 
2L2218 was caused by difficulties in obtaining larvae with clones (only two out of 191 analysed larvae had clonal 
cells). 
 
Also the development of embryonic trachea in line 2L3443 was analysed, but no defects were found 
(data not shown). 
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Figure 3.22 Clonal terminal cells in wt (A, B) and mutant (C-H). In wt all branches of terminal cell have gas filled 
lumen (white arrow) In mutant cell, the lumen is present in part of the branches (white arrow in C and D) or stops 
within the branch (red arrowheads in C –F) or is completely absent (green arrows in G, H). Right panel shows bright 
field image of cells from left panel. 
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3.4.3.2 Survival test 
 
In order to find out at what stage mutation in line 2L3443 is causing lethality, survival test was 
performed as described for other two groups. 33.3% of the embryos from line 2L3443 did not hatch 
which suggests that the mutation is embryonic semi-lethal. The development of all mutant embryos 
was slowed down as 50% of embryos were still in embryo case after 24 hours, whereas after 48 
hours only 33.3% remained unhatched. For line 2L2218 it was not possible to collect enough 
embryos to perform the test. 
 
Line Counted 
embryos 
Non-hatched 
embryos after 
24h 
Non-hatched 
embryos 
after 48h 
Expected no of 
CyO/CyO or 
mutation/mutation 
embryos (25%) 
% of non-
hatched 
embryos 
FRT40A/CyO 187 54 46  46-47 24.6% 
2L3443 186 94 62 46-47 33.3% 
2L2218 - - - - - 
 
Table 3.10 Survival test for line 2L3443. FRT40A/CyO flies were used as a control, to estimate embryonic lethality 
caused by CyO chromosome. For line 2L2218 test was not performed. 
 
 
3.4.3.3 Mapping of group E3  
 
Although group E3 consists of two allelic lines only line 2L3443 could be used for mapping, due to 
the sickness of line 2L2218. I decided to map the phenotype not the lethality. The strategy using 
Single Nucleotide Polymorphism (SNP) makers (Berger, 2001) was chosen as a suitable tool. This 
method is based on sequence polymorphism between the strain used for mutagenesis and reference 
strain. It required generation of set of recombinants between mutant line and reference line 
spanning the whole chromosome arm. The recombinants were then analysed for presence of mutant 
phenotype and their chromosomes break points were mapped by molecular means. The combined 
results lead to mapping of the phenotype to the specific genomic region (see Material and Methods, 
section 2.2.7.1). 
69 recombinants between reference line (EP 511) and mutant line were generated and 52 of them 
were established as stable stocks. It is important to mention that all recombinant chromosomes had 
the distal tip from EP line and proximal part from 2L3443 line. Next, DNA was isolated from all 
recombinant lines. DNAs from 12 randomly chosen lines (line 5, 6, 12, 18, 24, 29, 30, 39, 45, 56, 
63 and 65) were tested by PLP and RFLP for 8 SNP markers distributed along the chromosome 
arm. Results are depicted in fig. 3.23 A. Simultaneously all recombinant lines were analysed for 
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presence of the mutant phenotype by MARCM analysis. Comparison of results from the molecular 
and phenotypic analysis led to placement of the mutation between markers 2L041 and 2L063. Next 
DNAs from all the recombinant lines were genotyped for these two markers as well as one localized 
between them (2L057). The obtained results (fig. 3.23 B) were than combined with information 
from phenotypic analysis and the mutation was mapped to the region of 850 kb between markers 
2L057 and 2L063 corresponding to the region 26A3-27B1 on the cytogenetic map. Several 
deficiencies covering the region (listed in Appendix tab. A.1 A) were crossed to both mutant lines 
and analysed for lethality complementation. As shown in fig 3.24, mutant lines did not complement 
Df(2L)BSC7 and Df(2L)BSC6 which narrowed down the region to 160kb (26D10 – 26F3).  
 
 
Figure 3.23 Summarised results of SNP mapping of mutation in line 2L3443. A –left column represents presence 
(green) or absence (red) of mutant phenotype of 12 randomly chosen recombinant lines, listed next to it; right column 
shows genotyping results for 8 PLP and RFLP markers (numbers above) in these recombinant lines, red indicates EP 
allele and green  FRT; white – unclear results; phenotype maps to region between marker 2L041 and 2L063; B – left 
column  - summarised phenotypic data of all recombinants; right column represents  corresponding genotyping results 
for markers 2L041, 2L057 and 2L063; colour code as in A;  phenotype maps between markers 2L057 and 2L063. 
 
 
There are 21 genes predicted in this region. They are listed in tab 3.11. Homozygous lethal mutants 
were available only for two of them, namely eyes absent and cup. For the remaining genes I decided 
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to sequence their coding region and search for sequence alteration in comparison to wild type allele 
of the respective gene on the FRT40A chromosome.  
 
 
Figure 3.24 Fine deficiency mapping of mutation in line 2L3443. Horizontal lines represent chromosomes in 
deficiencies: - solid lines - non-deleted fragments of chromosome, dotted lines - unclear regions and blank - deleted 
parts.  Green indicates complementation, red non-complementation. Vertical blue dotted lines mark region to which 
mutation was mapped. Markers 2L057 and 2L063 are indicated in red in graphic representation of genomic region 
(FlyBase; http://flybase.bio.indiana.edu). Genes are marked in blue. 
 
 
Primers were designed to amplify exons of the genes. After amplification PCR fragments were 
sequenced and compared with corresponding sequences obtained from original FRT40A stock. 
Additionally sequences were compared with genomic sequence of the genes obtained from ‘A 
Database of Drosophila Genes and Genomes’ (FlyBase; http://flybase.bio.indiana.edu). So far the 
following genes have been analysed: Osm-6, CG9596, CG11043, CG13766, CG11320, CG34009, 
CG11053 and CG31633. No mutations were found in the sequences analysed so far. 
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Gene Function 
CG31637 carbohydrate metabolism 
eyes absent (eya) eye development (Bolwig’s organ morphogenesis) 
Osm-6 microtubule based movement 
CG11015 mitochondrial electron transport, cytochrome c to oxygen 
CG9596 protein biosynthesis and metabolism 
CG11043 mitochondrial electron transport, cytochrome c to oxygen 
Ent2 nucleobase, nucleoside, nucleotide and nucleic acid meatbolism 
CG13766 unknown 
CG11319 cell  surface receptor linked signal transduction 
CG11050 unknown 
CG11320 cell adhesion, signal transduction 
CG34009 unknown 
CG11053 peptidyl - proline hydroxylation to 4-hydroxy L - proline 
Oatp26F organic anion transport 
CG31635 cell proliferation 
CG11098 unknown 
CG31633 unknown 
CG31636 coenzyme meatbolism 
CG11070 defence response, ubiquitin ligase complex 
CG13771 lipid metabolism 
cup chromosome organisation and biogenesis, involved in oogenesis 
 
Table 3.11 Predicted genes in region to which mutation in 2L3443 line was mapped. Function information from 
FlyBase (http://flybase.bio.indiana.edu). 
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4. Discussion 
 
The development of the Drosophila tracheal system has been extensively studied in the last decade 
as it is a perfect model to analyse tubulogenesis. Several screens performed in the past (Samakovlis 
et al., 1996; Beitel and Krasnow, 2000; Cela and Llimargas, 2006; Hemphala et al., 2003), 
application of advanced imaging techniques (Ribeiro et al., 2002; Jazwinska et al., 2003; Ribeiro et 
al., 2004) and detailed analysis of known components of different signalling pathways gave an 
insight into the genetic control and cellular processes involved in trachea morphogenesis. However, 
many open questions remain: what are the downstream effectors of signalling cascades, which 
molecules are involved in cell remodelling and how do they orchestrate extensive cell shape 
changes and rearrangements. Since most of the studies concentrated on tracheal development in the 
embryo, not much is known about later stages, especially the molecular bases of terminal branching 
events during larval life. However, the analysis of tracheal development in the larva is hampered by 
a possible earlier requirement of the genes during embryogenesis. Thus, the genetic dissection of 
larval tracheal development requires different approaches, i.e. clonal analysis with MARCM 
system. This system allows to study the function of known genes but it can also be adopted to 
identify involvement of new genes in tracheal formation. The results obtain from the genetic screen 
presented here show that the MARCM system is a useful tool to identify novel genes involved in 
tracheal development. 
 
4.1 The MARCM screen 
 
The screen was designed to identify genes on the second chromosome affecting tracheal 
development. We chose the second chromosome because the first and the third chromosomes were 
screened by a similar approach in the group of M. Krasnow (personal communication). In total, we 
screened 4779 mutagenised lines and 344 of them did not fulfill wild type criteria (7.2% of analysed 
lines).  Defects observed in 230 lines do not seem to be trachea specific (4.8% of analysed lines) 
whereas in the remaining 114 they do (2.4%). Among the lines with trachea specific phenotypes, a 
large number (81) show terminal branching defects which proves that the chosen approach is 
suitable for revealing late involvement in the trachea morphogenesis. 
In 78% of lines, the mutations led to homozygous lethality. The lethality could be due to the 
mutation causing the clonal phenotype but it cannot be excluded that the lethality is caused by 
additional mutation or mutations on the second chromosome. Complementation tests based on 
lethality led to identification of 26 complementation groups, indicating that some genes were hit 
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more than once. Of these, one complementation group consists of eight members, another of six, 
eight of three and 16 of two. Most of the complementation groups consist of lines showing non-
tracheal specific defects (20). There are two within the the dorsal trunk class and three in the 
terminal branching group. Additionally, nine lines failed to complement members of more than one 
group. In the case of one group, all the members showed different tracheal phenotypes. These 
results indicate that some of the mutagenised lines carry more than one mutation and that the 
lethality is not necessarily associated with the tracheal defect.  
 
4.2 The mutant phenotypes  
 
The phenotypes observed in the 344 mutant lines were divided into five classes: A - no clones, B - 
low number of clonal cells, C – small clonal cells, D - dorsal trunk phenotypes and E – terminal 
branching phenotypes, and are discussed below. 
 
In the class A, no clonal cells were found. The absence of clonal cells could result either from cell 
lethal mutations or defects in the FRT site.  Mutations leading to cell lethality are most likely found 
in house keeping genes and thus not affecting tracheal development specifically. However, the 
discovery of two new alleles of varicose (involved in tracheal tube size control; Beitel and 
Krasnow, 2000) within this group indicates that some of the ‘no clones’ lines might have mutations 
affecting tracheal development. 
The lines from group B (low number of clonal cells) and C (small clonal cells) are also likely to 
carry mutations in genes not specifically required for tracheal morphogenesis. They could affect 
survival of the cells (group B) or the regulation of cell growth (group C).   
 
The remaining 144 lines belonging to group D (dorsal trunk defects) and E (terminal branching 
defects) show trachea specific phenotypes.   
The phenotypes observed in group D were: dorsal trunk bendings (fig. 3.12), presence of clonal 
cells only in dorsal trunk, reduced size of clonal cells in dorsal trunk (fig. 3.5) and absence or 
decreased number of clonal cells in dorsal trunk. The presence or absence of clonal cells in specific 
branches might be caused by mutations in genes involved in the establishment of cell fate or branch 
identity. Three signalling pathways have been implicated to play a role in these processes: the 
Decapentaplegic (Dpp), EGF and Wingless (Wg) pathways. Dpp signalling is required for 
dorsoventral cell migration (Llimargas and Casanova, 1997; Vincent et al., 1997) whereas EGF and 
Wg signalling pathways are involved in determination of dorsal trunk identity (Wappner et al., 
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1997; Chihara and Hayashi, 2000; Llimargas, 2000; Llimargas and Lawrence, 2001). In embryos 
mutant for the Dpp receptor thickveins (tkv) and two Dpp dependent transcription factors knirps 
(kni) and knirps like (expressed normally in a subset of cells forming the dorsal branches and the 
lateral trunk) cell migration into dorsal branches, lateral trunk and ganglionic branches is abolished 
(Vincent et al., 1997; Chen et al., 1998). Thus the presence of clonal cells only in the dorsal trunk 
could result from their disability to migrate dorso-ventraly in response to Dpp signalling. So far 
only tkv is known to be located on the left arm of the second chromosome and being part of the Dpp 
signalling pathway. Thus complementation analysis will be required to assay for possible new 
alleles of tkv. However a more interesting scenario would be  the identification of so far unknown 
gene acting downstream of Dpp. The presence of such genes have been implicated by the fact, that 
expression of kni in the trachea cannot rescue the tkv tracheal defects (Zelzer and Shilo, 2000). 
The absence of clonal cells in the dorsal trunk (class D IV) could be due to interferance in the EGF 
or Wg signalling cascades, since in the embryos in which these pathways are inactivated, the dorsal 
trunk does not form and may be transformed into an other branch identities. (Wappner et al., 1997; 
Chihara and Hayashi, 2000; Llimargas, 2000; Llimargas and Lawrence, 2001). Two genes were 
identified to play a crucial role in establishment of dorsal trunk: spalt, required for identity 
determination and ribbon, involved in anterior-posterior cell migration. Spalt is a target gene of 
EGF signalling (Kuhnlein and Schuh, 1996) while ribbon acts downstream of Wg and FGF 
pathways (Bradley and Andrew, 2001). As spalt is located on the left arm of the second 
chromosome, it is a possible candidate gene of class D IV phenotype. However, the phenotype 
could also be derived from mutations in unknown genes downstream of spalt, affecting tracheal cell 
fate and branch identity.  
The two other dorsal trunk phenotypes found in the screen, dorsal trunk bending and reduced size of 
clonal cells in the dorsal trunk, might be caused by mutations affecting cell - cell contacts. The 
dorsal trunk is the only branch with a multicellular lumen and with cell contacts based exclusively 
on intercellular junctions. Thus, it is possible that a defect restricted to this type of tube might result 
from a disturbance of cells interactions. However, on the bases of current knowledge it is difficult to 
suggest any mechanism or molecule that could lead to a reduction in the size of clonal cells only in 
the dorsal trunk.  
The dorsal trunk bendings phenotype was found in 10 lines, out of which eight are allelic to each 
other. This complementation group (D1) was studied in more details (section 3.4.1). The clonal 
cells within the dorsal trunk, causing the bend, are smaller than neighbouring wild type cells and 
misshapen. However, reduction in size and shape change cannot wholly explain the observed 
phenotype, since small clonal cells in the dorsal trunk found in other mutant lines do not cause any 
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bending. Also, cell adhesion defects are unlikely to be responsible for the phenotype since no 
difference could be observed in the distribution of the adherens junction component, β-catenin 
(arm) between mutant clonal cells and their neighbours. However, in order to exclude an 
involvement if cell-to-cell jucntions, other junctional markers should be analysed as well. Thus, the 
phenotype requires further investigation which together with the mapping and identification of the 
affected gene may give us an insight into the mechanism causing the bendings. 
 
The terminal branching defects characteristic for group E are of most interest to us. Within this 
class five distinct phenotypic subgroups could be identified: terminal branches crossing or fusing 
(fig. 3.7) decreased and expanded branching of terminal cells (figs 3.8 and 3.9), absence or reduced 
number of clonal cells in terminal branches and problems with lumen formation (fig. 3.10). 
Extensive cytoplasmic outgrowth and ramification of terminal cells are controlled by FGF 
signalling, dependent on the physiological needs of the target tissues (Jarecki et al., 1999).  
Although the branching pattern of terminal cells is variable, it is not unorganised. Ramification 
points are regularly spaced and terminal branches do not cross or fuse (Ghabrial et al., 2003). In the 
screen we found 24 mutant lines in which branch crossing or fusion occurred in clonal cells. 60% of 
them (14 lines) are homozygous lethal but only one complementation group (with two lines) was 
found. This would suggest that there are mutations in 13 independent genes causing homozygous 
lethality and terminal cell phenotype which is rather unlikely. Thus, we expect that at least some of 
the lines have additional lethal mutations on the chromosome and the terminal branches defect does 
not lead to lethality as such. 
  Not much is known about the mechanism which prevents neighbouring cells to cross or fuse their 
terminal branches. The bnl expression being restricted to a small target area and this gradient is 
enough to attract a migrating terminal cell but it is unlikely to regulate the spatial spreading of the 
cytoplasmic extensions on its own. Thus, there must be other cues involved in that process. The first 
evidence of such an involvment came from the study of Kato et al. (2004) which revealed a role for 
Hedgehog (Hh) and Dpp signalling in the restriction of the epidermal spreading area of the dorsal 
terminal branches. Hh functions as a permissive signal to allow migration of terminal cell 
extensions laterally and along the anterior-posterior axis while Dpp prevents dorsal migration. 
However, the effectors are unknown and it is unclear whether the signalling acts directly on the cell 
cytoskeleton or is mediated by a nuclear transduction of the signal. It is also possible that other 
factors and tissues are involved in spatial restriction of terminal branching since it has been reported 
that mesodermal cells contribute to correct migration of dorsal branches in the embryo (Franch-
Marro and Casanova, 2000) and thus might be involved also in migration of terminal branches. This 
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is another aspect requiring further investigation. Thus some candidate mutations from the screen 
may turn out to affect genes expressed in signal receiving terminal cell, responding to the restrictive 
cue.  
The next interesting phenotypes observed within class E are reduced or expanded branching of 
terminal cells. One speculation on the class of genes mutated in these lines is the signalling 
response to oxygen needs. Under high oxygen conditions, terminal branches had fewer 
ramifications whereas at low oxygen concentrations branching was more extensive (Jarecki et al., 
1999). It is not fully understood how the Drosophila cells sense hypoxia and how it leads to 
induction of bnl expression which in turn regulates branch outgrowth. Thus a more detailed 
analyses and mapping of the identified mutants might uncover additional genes involved in hypoxia 
sensing and its cellular response. 
 
4.2.1 The phenotypes of candidate lines selected for further investigation. 
 
From the 114 lines, three complementation groups were considered most promising and chosen for 
further analysis and mapping. The selection criteria were based on interesting phenotype and larger 
number of alleles (in complementation group). The first criterion was fulfilled by two 
complementation groups (E2 and E3) showing defects in lumen formation in terminal branches and 
consist of two lines each. The second criterion was fulfilled by group D1 which consists of eight 
lines with dorsal trunk bendings at clonal cells position (discussed earlier). 
 
The lumen of terminal cells is a channel formed within the cytoplasm of a single cell. How it is 
formed and maintained is poorly understood. Similar structures are found also in other organisms, 
for eg: the finest capillaries of the vertebrate vascular system. In vitro studies of angiogenesis 
showed that cytoplasmic vesicles providing apical membrane are essential for lumen formation 
(Folkman and Haudenschild, 1980; Davis and Camarillo, 1996). In vivo analyses of vascular lumen 
formation in zebrafish together with results from earlier in vitro studies led to a model in which the 
formation and intracellular fusion of endothelial vacuoles drives vascular lumen formation (Kamei 
et al., 2006). It is likely that this is a common mechanism for tube formation during development 
and could be applied also during formation of lumen in terminal cells of Drosophila.   
In the two lines from group E3 (2L3443 and 2L2218), lumen formation is completely or partially 
abolished (section 3.4.3.1). The phenotype indicates that the formation of cytoplasmic vesicles is 
impaired rather than their fusion, although how it is, remains unclear. The mutation was mapped to 
a region of ~160kb in the 26D10-26F3 interval on the cytogenetic map. There are 21 predicted 
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genes in this region. None of them had a previous involvement in tracheal development. In the case 
of five predicted genes, no functional information is available. To map the mutation I decided to 
sequence these genes and compare the mutant sequence with its wild type allele. So far eight of the 
genes including four with unknown function were analysed but no mutation was found.  
The lines from group E2 (2L3637 and 2L4501) show also no lumen formation in the terminal 
branches. Additionally, clonal cells on secondary branches lack the typical gas filling (section 
3.4.2.1). This indicates that the mutation is not only affecting the formation or maintenance of the 
subcellular lumen but also the one formed by single cell, wrapped around the lumen. The fact that 
in some clonal cells parts of the lumen were still present (visualised by the absence of cytoplasmic 
marker signal in luminal space; fig.3.19) but gas filling was missing, together with the observation 
of properly formed lumen of secondary branches in the mutant embryos suggest, that the observed 
phenotype may result not from lumen formation but lumen maintenance defect. One possible 
explanation of the phenotype and its occurance only in terminal cells and secondary branches could 
be, that secretion of cuticular lining of the branches is affected which may lead to lumen collapse. 
However, this hypothesis requires further investigation. If it were true, our mutants would indicate 
that the proper chitin metabolism and cuticle formation might not only be involved in the control of 
lumen size in the embryonic tracheal system (Araujo et al., 2005; Devine et al., 2005; Tonning et 
al., 2005; Moussian et al., 2006; Luschnig et al., 2006; Wang et al., 2006) but also in later stages of 
development. 
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5. Conclusions 
 
The aim of this study was to perform a genetic mosaic screen in order to reveal new molecules 
involved in tracheal development. The identification of 114 lines showing trachea specific defects 
indicate that the chosen approach was a suitable tool for studying tubulogenesis. Although so far 
none of the mutations have beed mapped to individual genes, and no mechanism explaining the 
different phenotypes could be proposed, the screen provides a collection of mutants, whose detailed 
analyses will help our understanding of such processes like lumen formation in terminal cells, their 
branching control, lumen formation and stabilisation in secondary branches or cell behaviour in 
multicellular tubes. 
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7. Appendix 
 
Table A.1 Deficiencies stocks used for mapping 
 
A) Deficiencies used for fine mapping  
Df symbol Genotype Cytology References 
Df(2L)ED292 w1118; Df(2L)ED292, P{3'.RS5+3.3'}ED292/SM6a 25F5;26B2 Bloomington #9182 
Df(2L)Exel7024 w1118;Df(2L)Exel7024,P+PBac{XP5.RB3}Exel7024/CyO 26A1;26A8 Exelixis, Inc./ 
Bloomington #7799 
Df(2L)ED347 w1118; Df(2L)ED347, P{3'.RS5+3.3'}ED347/SM6a 25F5;26B5 Bloomington #9272 
Df(2L)ED354 w1118; Df(2L)ED354, P{3'.RS5+3.3'}ED354/SM6a 26B1;26B5 Bloomington #9187 
Df(2L)ED385 w1118; Df(2L)ED385, P{3'.RS5+3.3'}ED385/SM6a 26B1;26D7 Bloomington #9341 
Df(2L)BSC6 Df(2L)BSC6, dpov1 cn1/SM6a 26D3-E1; 
26F4-7 
Bloomington #6338 
Df(2L)Exel7027 w1118; Df(2L)Exel7027, P+PBac{XP5.RB3}Exel7027/CyO 26F5;27B1 Exelixis, Inc./ 
Bloomington #7801 
Df(2L)BSC7 w1118; Df(2L)BSC7/CyO
 
26D10-E1; 
27C1 
Bloomington #6374 
Df(2L)ED6569 w1118; Df(2L)ED6569, P{3'.RS5+3.3'}ED6569/SM6a 27A1;27C4 Bloomington #8940 
Df(2L)Liprin-αR60 w*; Df(2L)Liprin-αR60, Liprin-αR60/CyO, P{ActGFP}JMR1 27A1;27A1 Bloomington #8561 
B) Bloomington Deficiency kit for 2L 
Df(2L)net-PMF Df(2L)net-PMF/SM6a 
 
21A1; 21B7-
8 
Bloomington #3638 
Df(2L)BSC16 Df(2L)BSC16, net1 cn1/SM6a
 
21C3-4; 
21C6-8 
Bloomington #6608 
Df(2L)ast2 
 
Df(2L)ast2/SM1 
 
21D1-2; 
22B2-3 
Bloomington #3084 
Df(2L)BSC37 Df(2L)BSC37/CyO 
 
22D2-3; 
22F1-2 
Bloomington #7144 
Df(2L)JS17 Df(2L)JS17, dppd-ho/CyO, P{en1}wgen11
 
23C1-2; 
23E1-2 
Bloomington #1567 
Df(2L)BSC28 Df(2L)BSC28/SM6a, bwk1
 
23C5-D1; 
23E2 
Bloomington #6875 
Df(2L)BSC31 Df(2L)BSC31, net1 cn1/CyO, b81f2 rk81f2
 
23E5; 23F4-
5 
Bloomington #6965 
Df(2L)drm-P2 y1 w*; Df(2L)drm-P2, P{lacW}Pdswk10101/SM6b
 
23F3-4; 
24A1-2 
Bloomington #6507 
Df(2L)ed1 Df(2L)ed1/CyO; P{ftz/lacC}1 24A2;24D4 Bloomington #5330 
Df(2L)ED250 w1118; Df(2L)ED250, P{3'.RS5+3.3'}ED250/SM6a 24F4;25A7 Bloomington #9270 
Df(2L)BSC110 w1118; Df(2L)BSC110, P+PBac{XP5.RB3}BSC110/CyO 25C1;25C3 Bloomington #8835 
Df(2L)BSC109 w1118; Df(2L)BSC109, P+PBac{XP5.RB3}BSC109/CyO 25C4;25C8 Bloomington #8674 
Df(2L)Exel6011 w1118; Df(2L)Exel6011, P{XP-U}Exel6011/CyO 25C8;25D5 Exelixis, Inc./ 
Bloomington #7497 
Df(2L)cl-h3 
 
Df(2L)cl-h3/SM6b 
 
25D2-4; 
26B2-5 
Bloomington #781 
Df(2L)BSC5 Df(2L)BSC5, w+mC/SM6a
 
26B1-2; 
26D1-2 
Bloomington #6299 
Df(2L)BSC6 Df(2L)BSC6, dpov1 cn1/SM6a 26D3-E1; 
26F4-7 
Bloomington #6338 
Df(2L)BSC7 w1118; Df(2L)BSC7/CyO
 
26D10-E1; 
27C1 
Bloomington #6374 
Df(2L)spdj2 w*; Df(2L)spdj2, wgspd-j2/CyO, P{ftz/lacB}E3
 
27C1-2; 28A Bloomington #2414 
Df(2L)Dwee1-
W05 
Df(2L)Dwee1-W05/CyO; P{ftz/lacC}1
 
27C2-3; 
27C4-5 
Bloomington #5420 
Df(2L)Trf-C6R31 y1 w67c23; Df(2L)Trf-C6R31/CyO 28DE Bloomington #140 
Df(2L)TE29Aa-11 In(1)w[m4h],,y1; Df(2L)TE29Aa-11, dp*/CyO 28E4-7; 
29B2-C1 
Bloomington #179 
Df(2L)BSC111 w1118;Df(2L)BSC111, P+PBac{XP5.WH5}BSC111/CyO 28F5;29B1 Bloomington #8836 
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Df(2L)ED611 w1118; Df(2L)ED611, P{3'.RS5+3.3'}ED611/SM6a 29B4;29C3 Bloomington #9298 
Df(2L)N22-14 
 
Df(2L)N22-14/CyO 
 
29C1-2; 
30C8-9 
Bloomington #2892 
Df(2L)BSC17 Df(2L)BSC17/SM6a 30C3-5; 30F1 Bloomington #6478 
Df(2L)BSC50 
 
Df(2L)BSC50/SM6a 
 
30F4-5; 
31B1-4 
Bloomington #8469 
Df(2L)J2 y*; Df(2L)J2/SM1 31B;32A Bloomington #3366 
Df(2L)BSC36 Df(2L)BSC36/SM6a, bwk1
 
32D1; 32D4-
E1 
Bloomington #7143 
Df(2L)FCK-20 Df(2L)FCK-20, dpov1 bw1/CyO, P{sevRas1.V12}FK1
 
32D1; 32F1-
3 
Bloomington #5869 
Df(2L)Prl Df(2L)Prl, Prl1 nubPrl/CyO
 
32F1-3; 
33F1-2 
Bloomington #3079 
Df(2L)BSC30 Df(2L)BSC30/SM6a, bwk1
 
34A3; 34B7-
9 
Bloomington #6999 
Df(2L)TE35BC-24 Df(2L)TE35BC-24, b1 pr1 pk1 cn1 sp1/CyO
 
35B4-6; 
35F1-7 
Bloomington #3588 
Df(2L)r10 Df(2L)r10, cn1/CyO
 
35D1; 36A6-
7 
Bloomington #1491 
Df(2L)cact-
255rv64 
Df(2L)cact-255rv64, cactchif64/CyO; ry506
 
35F-36A; 
36D 
Bloomington #2583 
Df(2L)TW137 Df(2L)TW137, cn1 bw1/CyO, Dp(2;2)M(2)m+
 
36C2-4; 
37B9-C1 
Bloomington #420 
Df(2L)Exel6049 w1118; Df(2L)Exel6049, P{XP-U}Exel6049/CyO 40A5;40D3 Exelixis,Inc./ 
Bloomington #7531 
Df(2L)C' Df(2L)C'/CyO  Bloomington #4959 
C) Exelixis Deficiency Kit for 2L 
Df(2L)Exel6001 w1118; Df(2L)Exel6001, P{XP-U}Exel6001/CyO 21B1;21B1 Exelixis,Inc./ 
Bloomington #7488 
Df(2L)Exel7002 w1118; Df(2L)Exel7002, P+PBac{XP5.RB3}Exel7002/CyO
 
21B4;21B7 Exelixis,Inc./ 
Bloomington #7772 
Df(2L)Exel8003 w1118; Df(2L)Exel8003, P+PBac{XP5.RB3}Exel8003/CyO
 
21D1;21D2 Exelixis,Inc./ 
Bloomington #7774 
Df(2L)Exel6002 w1118; Df(2L)Exel6002, P{XP-U}Exel6002/CyO 
 
21D2;21D3 Exelixis,Inc./ 
Bloomington #7489 
Df(2L)Exel7005 w1118;Df(2L)Exel7005, P+PBac{XP5.WH5}Exel7005/CyO
 
21D2;21D4 Exelixis,Inc./ 
Bloomington #7775 
Df(2L)Exel6003 w1118; Df(2L)Exel6003, P{XP-U}Exel6003/CyO
 
21D3;21E3 Exelixis,Inc./ 
Bloomington #7490 
Df(2L)Exel6004 w1118; Df(2L)Exel6004, P{XP-U}Exel6004/CyO  
 
21E3;21F2 Exelixis,Inc./ 
Bloomington #7491 
Df(2L)Exel7006 w1118; Df(2L)Exel7006, P+PBac{XP5.WH5}Exel7006/CyO
 
21F2;21F4 Exelixis,Inc./ 
Bloomington #7776 
Df(2L)Exel6005 w1118; Df(2L)Exel6005, P{XP-U}Exel6005/CyO
 
22A3;22B1 Exelixis,Inc./ 
Bloomington #7492 
Df(2L)Exel7007 w1118; Df(2L)Exel7007, P+PBac{XP5.RB3}Exel7007/CyO
 
22B1;22B5 Exelixis,Inc./ 
Bloomington #7778 
Df(2L)Exel8005 w1118; Df(2L)Exel8005, P+PBac{XP5.WH5}Exel8005/CyO
 
22B2;22B8 Exelixis,Inc./ 
Bloomington #7779 
Df(2L)Exel6006 w1118; Df(2L)Exel6006, P{XP-U}Exel6006/CyO
 
22B5;22D1 Exelixis,Inc./ 
Bloomington #8000 
Df(2L)Exel7008 w1118; Df(2L)Exel7008, P+PBac{XP5.RB3}Exel7008/CyO
 
22B8;22D1 Exelixis,Inc./ 
Bloomington #7780 
Df(2L)Exel6007 w1118; Df(2L)Exel6007, P{XP-U}Exel6007/CyO
 
22D1;22E1 Exelixis,Inc./ 
Bloomington #7493 
Df(2L)Exel7010 w1118; Df(2L)Exel7010, P+PBac{XP5.WH5}Exel7010/CyO
 
22D4;22E1 Exelixis,Inc./ 
Bloomington #7782 
Df(2L)Exel7011 w1118; Df(2L)Exel7011, P+PBac{XP5.WH5}Exel7011/CyO
 
22E1;22F3 Exelixis,Inc./ 
Bloomington #7783 
Df(2L)Exel6008 w1118; Df(2L)Exel6008, P{XP-U}Exel6008/CyO
 
22F3;23A3 Exelixis,Inc./ 
Bloomington #7494 
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Df(2L)Exel6277 w1118; Df(2L)Exel6277, P{XP-U}Exel6277/CyO
 
23A2;23B1 Exelixis,Inc./ 
Bloomington #7744 
Df(2L)Exel7014 w1118; Df(2L)Exel7014, P+PBac{XP5.RB3}Exel7014/CyO
 
23C4;23D1 Exelixis,Inc./ 
Bloomington #7784 
Df(2L)Exel7015 w1118; Df(2L)Exel7015, P+PBac{XP5.WH5}Exel7015/CyO
 
23D1;23E3 Exelixis,Inc./ 
Bloomington #7785 
Df(2L)Exel8008 w1118; Df(2L)Exel8008, P+PBac{XP5.RB3}Exel8008/CyO
 
23E3;23E5 Exelixis,Inc./ 
Bloomington #7786 
Df(2L)Exel7016 w1118; Df(2L)Exel7016, P+PBac{XP5.WH5}Exel7016/CyO
 
23F3;23F3 Exelixis,Inc./ 
Bloomington #7787 
Df(2L)Exel7018 w1118; Df(2L)Exel7018, P+PBac{XP5.WH5}Exel7018/CyO
 
24A1;24C2 Exelixis,Inc./ 
Bloomington #7789 
Df(2L)Exel6009 w1118; Df(2L)Exel6009, P{XP-U}Exel6009/CyO
 
24C3;24C8 Exelixis,Inc./ 
Bloomington #7495 
Df(2L)Exel8010 w1118; Df(2L)Exel8010, P+PBac{XP5.RB3}Exel8010/CyO
 
24C8;24D4 Exelixis,Inc./ 
Bloomington #7790 
Df(2L)Exel6010 w1118; Df(2L)Exel6010, P{XP-U}Exel6010/CyO
 
25A6;25B1 Exelixis,Inc./ 
Bloomington #7496 
Df(2L)Exel9062 w1118; Df(2L)Exel9062, P+PBac{XP5.RB3}Exel9062/CyO 
 
25B1;25B1 Exelixis,Inc./ 
Bloomington #7792 
Df(2L)Exel8012 w1118; Df(2L)Exel8012, P+PBac{XP5.RB3}Exel8012/ CyO 
 
25B1;25B5 Exelixis,Inc./ 
Bloomington #7793 
Df(2L)Exel7021 w1118; Df(2L)Exel7021, P+PBac{XP5.RB3}Exel7021/ CyO 
 
25B3;25B9 Exelixis,Inc./ 
Bloomington #7795 
Df(2L)Exel8013 w1118; Df(2L)Exel8013, P+PBac{XP5.RB3}Exel8013/ CyO 
 
25B8;25B10 Exelixis,Inc./ 
Bloomington #7796 
Df(2L)Exel7022 w1118; Df(2L)Exel7022, P+PBac{XP5.WH5}Exel7022/ CyO 
 
25B10;25C3 Exelixis,Inc./ 
Bloomington #7794 
Df(2L)Exel6011 w1118;Df(2L)Exel6011, P{XP-U}Exel6011/ CyO 
 
25C8;25D5 Exelixis,Inc./ 
Bloomington #7497 
Df(2L)Exel6012 w1118; Df(2L)Exel6012, P{XP-U}Exel6012/ CyO 
 
25D5;25E6 Exelixis,Inc./ 
Bloomington #7498 
Df(2L)Exel7023 w1118; Df(2L)Exel7023, P+PBac{XP5.WH5}Exel7023/ CyO 
 
25E5;25F1 Exelixis,Inc./ 
Bloomington #7797 
Df(2L)Exel6256 w1118; Df(2L)Exel6256, P{XP-U}Exel6256/ CyO 
 
25E6;25F2 Exelixis,Inc./ 
Bloomington #7724 
Df(2L)Exel8016 w1118; Df(2L)Exel8016, P+PBac{XP5.WH5}Exel8016/ CyO 
 
25E6;25F2 Exelixis,Inc./ 
Bloomington #7798 
Df(2L)Exel6013 w1118; Df(2L)Exel6013, P{XP-U}Exel6013/ CyO 
 
25F2;25F4 Exelixis,Inc./ 
Bloomington #7499 
Df(2L)Exel6014 w1118; Df(2L)Exel6014, P{XP-U}Exel6014/ CyO 
 
25F5;26A3 Exelixis,Inc./ 
Bloomington #7500 
Df(2L)Exel7024 w1118; Df(2L)Exel7024, P+PBac{XP5.RB3}Exel7024/ CyO 
 
26A1;26A8 Exelixis,Inc./ 
Bloomington #7799 
Df(2L)Exel6015 w1118; Df(2L)Exel6015, P{XP-U}Exel6015/ CyO 
 
26B9;26C1 Exelixis,Inc./ 
Bloomington #7501 
Df(2L)Exel6016 w1118;Df(2L)Exel6016, P{XP-U}Exel6016/ CyO 
 
26C1;26D1 Exelixis,Inc./ 
Bloomington #7502 
Df(2L)Exel9038 w1118; Df(2L)Exel9038, P{XP-U}Exel9038/CyO
 
26C2;26C3 Exelixis,Inc./ 
Bloomington #7800 
Df(2L)Exel7027 w1118; Df(2L)Exel7027, P+PBac{XP5.RB3}Exel7027/CyO
 
26F5;27B1 Exelixis,Inc./ 
Bloomington #7801 
Df(2L)Exel7029 w1118;Df(2L)Exel7029,P+PBac{XP5.WH5}Exel7029/CyO 27C4;27D4 Exelixis,Inc./ 
Bloomington #7802 
Df(2L)Exel8019 w1118; Df(2L)Exel8019, P+PBac{XP5.WH5}Exel8019 /CyO 27E2;27E4 Exelixis,Inc./ 
Bloomington #7803 
Df(2L)Exel6017 w1118; Df(2L)Exel6017, P{XP-U}Exel6017/CyO 27E4;27F5 Exelixis,Inc./ 
Bloomington #7503 
Df(2L)Exel7031 w1118; Df(2L)Exel7031, P+PBac{XP5.WH5}Exel7031 /CyO 27F3;28A1 Exelixis,Inc./ 
Bloomington #7804 
Df(2L)Exel6018 w1118; Df(2L)Exel6018, P{XP-U}Exel6018 /CyO 28B1;28C1 Exelixis,Inc./ 
Bloomington #7504 
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Df(2L)Exel9031 w1118; Df(2L)Exel9031, PBac{RB3.WH3}Exel9031 /CyO 28B4;28C1 Exelixis,Inc./ 
Bloomington #7805 
Df(2L)Exel7034 w1118; Df(2L)Exel7034, P+PBac{XP5.RB3}Exel7034/CyO 28E1;28F1 Exelixis,Inc./ 
Bloomington #7807 
Df(2L)Exel8021 w1118; Df(2L)Exel8021, P+PBac{XP5.WH5}Exel8021/CyO 29C1;29D1 Exelixis,Inc./ 
Bloomington #7808 
Df(2L)Exel7038 w1118; Df(2L)Exel7038, P+PBac{XP5.RB3}Exel7038/CyO 29C4;29D4 Exelixis,Inc./ 
Bloomington #7809 
Df(2L)Exel7039 w1118; Df(2L)Exel7039, P+PBac{XP5.WH5}Exel7039/CyO 29D5;29F1 Exelixis,Inc./ 
Bloomington #7810 
Df(2L)Exel7040 w1118; Df(2L)Exel7040, P+PBac{XP5.WH5}Exel7040/CyO 29F1;29F6 Exelixis,Inc./ 
Bloomington #7811 
Df(2L)Exel6021 w1118; Df(2L)Exel6021, P{XP-U}Exel6021/CyO 29F7;29B1 Exelixis,Inc./ 
Bloomington #7505 
Df(2L)Exel8022 w1118; Df(2L)Exel8022, P+PBac{XP5.RB3}Exel8022/CyO 30B3;30B5 Exelixis,Inc./ 
Bloomington #7813 
Df(2L)Exel9064 w1118; Df(2L)Exel9064, PBac{RBr}Exel9064/CyO 30B4;30B5 Exelixis,Inc./ 
Bloomington #7814 
Df(2L)Exel6022 w1118; Df(2L)Exel6022, P{XP-U}Exel6022/CyO 30B5;30B11 Exelixis,Inc./ 
Bloomington #7506 
Df(2L)Exel7042 w1118; Df(2L)Exel7042, P+PBac{XP5.WH5}Exel7042/CyO 30B10;30C1 Exelixis,Inc./ 
Bloomington #7812 
Df(2L)Exel9040 w1118; Df(2L)Exel9040, P+PBac{XP5.WH5}Exel9040/CyO 30C1;30C1 Exelixis,Inc./ 
Bloomington #7815 
Df(2L)Exel6024 w1118; Df(2L)Exel6024, P{XP-U}Exel6024/CyO 30C1;30C9 Exelixis,Inc./ 
Bloomington #7507 
Df(2L)Exel6025 w1118; Df(2L)Exel6025, P{XP-U}Exel6025/CyO 30C9;30E1 Exelixis,Inc./ 
Bloomington #7508 
Df(2L)Exel7043 w1118; Df(2L)Exel7043, P+PBac{XP5.RB3}Exel7043/CyO 30D1;30F1 Exelixis,Inc./ 
Bloomington #7816 
Df(2L)Exel8024 w1118; Df(2L)Exel8024, 
P+PBac{XP5.WH5}Exel8024/CyO? 
31A2;31B1 Exelixis,Inc./ 
Bloomington #7817 
Df(2L)Exel9032 w1118; Df(2L)Exel9032, PBac{RB5.WH5}Exel9032/CyO 31A3;31B1 Exelixis,Inc./ 
Bloomington #7818 
Df(2L)Exel7046 w1118; Df(2L)Exel7046, P+PBac{XP5.WH5}Exel7046/CyO 31C3;31D9 Exelixis,Inc./ 
Bloomington #7819 
Df(2L)Exel7048 w1118; Df(2L)Exel7048, P+PBac{XP5.RB3}Exel7048/CyO 31E3;31F5 Exelixis,Inc./ 
Bloomington #7999 
Df(2L)Exel8026 w1118; Df(2L)Exel8026, P+PBac{XP5.RB3}Exel8026/CyO 31F5;32B1 Exelixis,Inc./ 
Bloomington #7820 
Df(2L)Exel7049 w1118; Df(2L)Exel7049, P+PBac{XP5.RB3}Exel7049/CyO 32B1;32C1 Exelixis,Inc./ 
Bloomington #7821 
Df(2L)Exel6027  w1118; Df(2L)Exel6027, P{XP-U}Exel6027/CyO 32D1;32D5 Exelixis,Inc./ 
Bloomington #7510 
Df(2L)Exel6028 w1118; Df(2L)Exel6028, P{XP-U}Exel6028/CyO 32D5;32E4 Exelixis,Inc./ 
Bloomington #7511 
Df(2L)Exel6029 w1118; Df(2L)Exel6029, P{XP-U}Exel6029/CyO 32E4;32F2 Exelixis,Inc./ 
Bloomington #7512 
Df(2L)Exel6030 w1118; Df(2L)Exel6030, P{XP-U}Exel6030/CyO 33A2;33B3 Exelixis,Inc./ 
Bloomington #7513 
Df(2L)Exel6031 w1118; Df(2L)Exel6031, P{XP-U}Exel6031/CyO 33B3;33C2 Exelixis,Inc./ 
Bloomington #7514 
Df(2L)Exel6032 w1118; Df(2L)Exel6032, P{XP-U}Exel6032/CyO 33C2;33D4 Exelixis,Inc./ 
Bloomington #7515 
Df(2L)Exel6033 w1118; Df(2L)Exel6033, P{XP-U}Exel6033/CyO 33E4;33F2 Exelixis,Inc./ 
Bloomington #7516 
Df(2L)Exel6034 w1118; Df(2L)Exel6034, P{XP-U}Exel6034/CyO 33F2;34A1 Exelixis,Inc./ 
Bloomington #7517 
Df(2L)Exel 8028 w1118; Df(2L)Exel 8028, P+PBac{XP5.WH5}Exel8028/CyO 34A1;34A2 Exelixis,Inc./ 
Bloomington #7822 
Df(2L)Exel7055 w1118; Df(2L)Exel7055, P+PBac{XP5.WH5}Exel7055/CyO 34A2;34A7 Exelixis,Inc./ 
Bloomington #7823 
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Df(2L)Exel7059 w1118; Df(2L)Exel7059, P+PBac{XP5.RB3}Exel7059/CyO 34D3;34E1 Exelixis,Inc./ 
Bloomington #7826 
Df(2L)Exel6035 w1118; Df(2L)Exel6035, P{XP-U}Exel6035/CyO 35A3;35B2 Exelixis,Inc./ 
Bloomington #7518 
Df(2L)Exel6036 w1118; Df(2L)Exel6036, P{XP-U}Exel6036/CyO 35B1;35B2 Exelixis,Inc./ 
Bloomington #7519 
Df(2L)Exel8033 w1118; Df(2L)Exel8033, P+PBac{XP5.WH5}Exel8033/CyO 35B1;35B8 Exelixis,Inc./ 
Bloomington #7828 
Df(2L)Exel8034 w1118; Df(2L)Exel8034, P+PBac{XP5.WH5}Exel8034/CyO 35C5;35D2 Exelixis,Inc./ 
Bloomington #7830 
Df(2L)Exel7063 w1118; Df(2L)Exel7063, P+PBac{XP5.RB3}Exel7063/CyO 35D2;35D4 Exelixis,Inc./ 
Bloomington #7831 
Df(2L)Exel6038 w1118; Df(2L)Exel6038, P{XP-U}Exel6038/CyO 35D6;35E2 Exelixis,Inc./ 
Bloomington #7521 
Df(2L)Exel7066 w1118; Df(2L)Exel7066, P+PBac{XP5.WH5}Exel7066/CyO 36A1;36A12 Exelixis,Inc./ 
Bloomington #7833 
Df(2L)Exel6039 w1118; Df(2L)Exel6039, P{XP-U}Exel6039/CyO 36A10;36B3 Exelixis,Inc./ 
Bloomington #7522 
Df(2L)Exel7067 w1118; Df(2L)Exel7067, P+PBac{XP5.RB3}Exel7067/CyO 36A12;36B2 Exelixis,Inc./ 
Bloomington #7834 
Df(2L)Exel8036 w1118; Df(2L)Exel8036, P+PBac{XP5.RB3}Exel8036/CyO 36B1;36C9 Exelixis,Inc./ 
Bloomington #7835 
Df(2L)Exel7068 w1118; Df(2L)Exel7068, P+PBac{XP5.RB3}Exel7068/CyO 36C7;36C10 Exelixis,Inc./ 
Bloomington #7838 
Df(2L)Exel9044 w1118; Df(2L)Exel9044, PBac{WHr}Exel9044/CyO 36C10;36C1
1 
Exelixis,Inc./ 
Bloomington #7836 
Df(2L)Exel7069 w1118; Df(2L)Exel7069, P+PBac{XP5.RB3}Exel7069/CyO 36C10;36D1 Exelixis,Inc./ 
Bloomington #7837 
Df(2L)Exel7070 w1118; Df(2L)Exel7070, P+PBac{XP5.WH5}Exel7070/CyO 36D2;36E1 Exelixis,Inc./ 
Bloomington #7839 
Df(2L)Exel8038 w1118; Df(2L)Exel8038, P+PBac{XP5.RB3}Exel8038/CyO 36D3;36E3 Exelixis,Inc./ 
Bloomington #7840 
Df(2L)Exel9033 w1118; Df(2L)Exel9033, PBac{WHr}Exel9033  36F2;36F2 Exelixis,Inc./ 
Bloomington #7841 
Df(2L)Exel6041 w1118; Df(2L)Exel6041, P{XP-U}Exel6041/CyO 36F5;37A2 Exelixis,Inc./ 
Bloomington #7523 
Df(2L)Exel7071 w1118; Df(2L)Exel7071, P+PBac{XP5.RB3}Exel7071/CyO 37A1;37A4 Exelixis,Inc./ 
Bloomington #7843 
Df(2L)Exel7072 w1118; Df(2L)Exel7072, P+PBac{XP5.WH5}Exel7072/CyO 37A2;37B6 Exelixis,Inc./ 
Bloomington #7844 
Df(2L)Exel7073 w1118; Df(2L)Exel7073, P+PBac{XP5.WH5}Exel7073/CyO 37B1;37B9 Exelixis,Inc./ 
Bloomington #7845 
Df(2L)Exel8039 w1118; Df(2L)Exel8039, P+PBac{XP5.WH5}Exel8039/CyO 37B8;37B11 Exelixis,Inc./ 
Bloomington #7846 
Df(2L)Exel6042 w1118; Df(2L)Exel6042, P{XP-U}Exel6042/CyO 37B8;37C5 Exelixis,Inc./ 
Bloomington #7524 
Df(2L)Exel8040 w1118; Df(2L)Exel8040, P+PBac{XP5.WH5}Exel8040/CyO 37C1;37C5 Exelixis,Inc./ 
Bloomington #7847 
Df(2L)Exel6043 w1118; Df(2L)Exel6043, P{XP-U}Exel6043/CyO 37C5;37D7 Exelixis,Inc./ 
Bloomington #7525 
Df(2L)Exel7075 w1118; Df(2L)Exel7075, P+PBac{XP5.RB3}Exel7075/CyO 37D2;37E1 Exelixis,Inc./ 
Bloomington #7848 
Df(2L)Exel 8041 w1118; Df(2L)Exel 8041, P+PBac{XP5.RB3}Exel8041/CyO 37D7;37F2 Exelixis,Inc./ 
Bloomington #7849 
Df(2L)Exel9043 w1118; Df(2L)Exel9043, P+PBac{XP5.RB3}Exel9043/CyO 37E1;37E1 Exelixis,Inc./ 
Bloomington #7913 
Df(2L)Exel6044 w1118; Df(2L)Exel6044, P{XP-U}Exel6044/CyO 37F2;38A4 Exelixis,Inc./ 
Bloomington #7526 
Df(2L)Exel6045 w1118; Df(2L)Exel6045, P{XP-U}Exel6045/CyO 38A4;38A7 Exelixis,Inc./ 
Bloomington #7527 
Df(2L)Exel7077 w1118; Df(2L)Exel7077, P+PBac{XP5.RB3}Exel7077/CyO 38A7;38B2 Exelixis,Inc./ 
Bloomington #7850 
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Df(2L)Exel6046 w1118; Df(2L)Exel6046, P{XP-U}Exel6046/CyO 38C2;38C7 Exelixis,Inc./ 
Bloomington #7528 
Df(2L)Exel7078 w1118; Df(2L)Exel7078, P+PBac{XP5.WH5}Exel7078/CyO 38C7;38D4 Exelixis,Inc./ 
Bloomington #7851 
Df(2L)Exel7079 w1118; Df(2L)Exel7079, P+PBac{XP5.WH5}Exel7079/CyO 38E6;38F3 Exelixis,Inc./ 
Bloomington #7852 
Df(2L)Exel7080 w1118; Df(2L)Exel7080, P+PBac{XP5.RB3}Exel7080/CyO 38F3;39A2 Exelixis,Inc./ 
Bloomington #7853 
Df(2L)Exel6047 w1118; Df(2L)Exel6047, P{XP-U}Exel6047/CyO 39A2;39B4 Exelixis,Inc./ 
Bloomington #7529 
Df(2L)Exel6048 w1118; Df(2L)Exel6048, P{XP-U}Exel6048/CyO 39B4;39D1 Exelixis,Inc./ 
Bloomington #7530 
Df(2L)Exel7081 w1118; Df(2L)Exel7081, P+PBac{XP5.WH5}Exel7081/CyO 39D1;39E6 Exelixis,Inc./ 
Bloomington #7855 
Df(2L)Exel6049 w1118; Df(2L)Exel6049, P{XP-U}Exel6049/CyO 39E7;40D3 Exelixis,Inc./ 
Bloomington #7531 
 
 
Table A.2 Oligos used for sequencing of candidate genes. 
Gene Oligo Sequence 
CG13766 CG13766F1 GAGGCGTAAACCATTCCAAA 
 CG13766R1 GGAGGGAAGCAAGCGTCTA 
 CG13766F2 GGCCACTTCCACATCCACTA 
 CG13766R2 TTTGGAACGTGCACAAAAAG 
 CG13766F3 TACGCAGTTGGTGACAGCTC 
 CG13766R3 GCTACCTGGTCCCACTGTTT 
CG31633 CG31633F1 GCGGTGAATGATATCCAAGAA 
 CG31633R1 CGAACGAAGCCTTTGAAAAT 
 CG31633F2 CCAATTCAATACATTCGTCAGG 
 CG31633R2 TGGAAGCATAAGGGGTCAAG 
 CG31633F3 CAAGAGCGGAAAGCAATAGG 
 CG31633R3 TTGATCTACTTGGGCGATGA 
 CG31633F4 AGCACAGCTGAAGGTCCAGT 
 CG31633R4 GGAACCCAACTGTGGAATGT 
CG11320 CG11320F1 GAAGTTTGATGCGAGTGCTG 
 CG11320R1 GTCAGGATGTGGTTCGTTCC 
 CG11320F2 CAGTATCGGAGTCGCTTCCT 
 CG11320R2 ATGTTTGGCGTCTGAGTTCC 
CG11043 CG11043F1 CAGCCGAGGAAAATTGCTTA 
 CG11043R1 CTTGGCCAGCAGCATTTC 
 CG11043F2 GCGTCCCATATCCACAACTC 
 CG11043R2 CTACCAGATCCTGCCCAATC 
CG11053 CG11053F1 AAGAGGCCCTAATGGGAATG 
 CG11053R1 CCCAGAATCATCTCCTCTCG 
 CG11053F2 AGTTTCCACCAGGACCTCAA 
 CG11053R2 TCGATCACCTTCCTCAGTCA 
 CG11053F3 CTGACTGAGGAAGGTGATCG 
 CG11053R3 GGCTCATCATAAGCTGGCTA 
osm6 osm6F1 TTTGAATTCGAGTCGCCAAC 
 osm6R1 GAGCGACAACAAGCACTTCA 
 osm6F2 GTCCTTAAGCAGGCGGTTG 
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 osm6R2 GAGCCGGAGTTCAATACCAA 
 osm6F3 CACATGGACTCGCAAACAAC 
 osm6R3 GCATGAAAAATGTCAAGCAAGC 
CG34009 CG34009F1 TTGAACAGCGGGATAGTTATGT 
 CG34009R1a AATTTAGGCGTTTGCTGGAA 
 CG34009F2 GGCGAAAGGAATCACAATCA 
 CG34009R2 GAAAATGTGCGCCGAATAAA 
 CG34009F3 GCGGGTTACAAAAGTTCAGC 
 CG34009R3 ATTGCACAGCACCGTCTTTC 
 CG34009F4 GCGGAGAATAAAGGCCAACT 
 CG34009R4 AGGCCAGAATGAAGAAACGA 
 CG34009F5 GTTTTCGCAGCAGAATGTTG 
 CG34009R5 CCCTTGAAATTGAGAAAACG 
 CG34009F6 TGTCCAATCCCCTAAATTCC 
 CG34009R6 TCGAGCTCTTTTCGTTTTGG 
CG11015 CG11015F1 AAGTTCGGTTGATTGTTGCAC 
 CG11015R1 GTGGGTCCAAATCTGATGCT 
 CG11015F2 GACACCACAGTGCGGAGTTA 
 CG11015R2 GTTTAAACGCGGTGTGTAGC 
 CG11015F3 GATTAGCTACACACCGCGTTT 
 CG11015R3 CCCACTTTGAGTGAGTTGAATC 
CG11050 CG11050F1 CAGATCAAGTGCTTTCAATTCG 
 CG11050R1 CCGAACTTCGCTTGACTAGAG 
 CG11050F2 GGAGCCACAAAGACACTGGT 
 CG11050R2 AAATCAAAACACGCAGGACA 
 CG11050F3 GCATTGCACTTTGTTAGAACG 
 CG11050R3 GGACATCCCTCTGCTCGTAG 
 CG11050F4 TACGAGCATGGACAGACTGC 
 CG11050R4 AGAATTCGATCCGCAACTTT 
 CG11050F5 CCTACCTCGACACGCTCATAG 
 CG11050R5 CCAACCGCTTTGGATAATGT 
CG9596 CG9596F1 AGTGCGGCCACTACTTCATC 
 CG9596R1 GGAACAACCTGAGGCGATAG 
 CG9596F2 GGAGGTCCCTTTGCTCCTAT 
 CG9596R2 CAACGACTCCAGCAAAATCA 
 CG9596F3 CTTGGCGGTAGAAGATGTCC 
 CG9596R3 TCACATGCAACAGGTGACTAGA 
 
 
Table A.3 List of lines identified in the screen 
Line Class Lethal Phenotype 
2L0036 A yes no clones 
2L0044 A yes no clones 
2L0058 A yes no clones, convoluted DT in homozygous embroys 
2L0067 A yes no clones, no negative clones in wing imaginal disc 
2L0218 A yes no clones 
2L0243 A yes no clones 
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2L0358 A yes no clones, no clones in wing imaginal disc, mutated FRT site 
2L0364 A yes no clones 
2L0437 A yes no clones 
2L0446 A yes no clones 
2L455 A yes no clones 
2L0476 A yes no clones 
2L0483 A yes no clones 
2L0567 A yes no clones 
2L0695 A yes no clones 
2L0702 A yes no clones 
2L0719 A yes no clones 
2L0728 A yes no clones 
2L0882 A yes no clones 
2L1066 A yes no clones 
2L1083 A yes no clones 
2L1145 A yes no clones 
2L1159 A yes no clones 
2L1219 A yes no clones 
2L1290 A yes no clones 
2L1313 A yes no clones 
2L1498 A yes no clones 
2L1573 A yes no clones 
2L1623 A yes no clones, does not complement varicose 
2L1625 A yes no clones 
2L1673 A yes no clones 
2L1681 A yes no clones 
2L1688 A yes no clones 
2L1713 A yes no clones 
2L1810 A yes no clones 
2L1846 A yes no clones 
2L1916 A yes no clones 
2L1930 A yes no clones 
2L1936 A yes no clones 
2L1961 A yes no clones 
2L1979 A yes no clones 
2L1990 A yes no clones 
2L2001 A yes no clones 
2L2020 A yes no clones 
2L2069 A yes no clones 
2L2071 A yes no clones 
2L2077 A yes no clones 
2L2081 A yes no clones 
2L2087 A yes no clones 
2L2115 A yes no clones 
2L2236 A yes no clones 
2L2238 A yes no clones 
2L2246 A yes no clones 
2L2268 A yes no clones 
2L2279 A yes no clones 
2L2283 A yes no clones 
2L2299 A yes no clones 
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2L2314 A yes no clones 
2L2338 A yes no clones 
2L2402 A yes no clones 
2L2438 A yes no clones 
2L2448 A yes no clones 
2L2450 A yes no clones 
2L2460 A yes no clones 
2L2491 A yes no clones 
2L2502 A yes no clones 
2L2508 A yes no clones 
2L2525 A yes no clones 
2L2556 A yes no clones 
2L2608 A yes no clones 
2L2613 A yes no clones 
2L2624 A yes no clones 
2L2626 A yes no clones 
2L2640 A yes no clones 
2L2714 A yes no clones 
2L2739 A yes no clones 
2L2765 A yes no clones 
2L2787 A yes no clones 
2L2850 A yes no clones 
2L2855 A yes no clones 
2L2964 A yes no clones 
2L2979 A yes no clones 
2L3002 A yes no clones 
2L3025 A yes no clones 
2L3025 A yes no clones 
2L3039 A yes no clones 
2L3065 A yes no clones 
2L3104 A yes no clones 
2L3114 A yes no clones 
2L3147 A yes no clones 
2L3185 A yes no clones 
2L3196 A yes no clones 
2L3198 A yes no clones 
2L3201 A yes no clones 
2L3209 A yes no clones 
2L3214 A yes no clones 
2L3215 A yes no clones, does not complement varicose 
2L3221 A yes no clones 
2L3233 A yes no clones 
2L3247 A yes no clones 
2L3253 A yes no clones 
2L3254 A yes no clones 
2L3259 A yes no clones 
2L32361 A yes no clones 
2L3266 A yes no clones 
2L3314 A yes no clones 
2L3319 A yes no clones 
2L3342 A yes no clones 
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2L3357 A yes no clones 
2L3413 A yes no clones 
2L3450 A yes no clones 
2L3452 A yes no clones 
2L3453 A yes no clones 
2L3511 A yes no clones 
2L3527 A yes no clones 
2L3524 A yes no clones 
2L3551 A yes no clones 
2L3606 A yes no clones 
2L3614 A yes no clones 
2L3619 A yes no clones 
2L3643 A yes no clones 
2L3671 A yes no clones 
2L3687 A yes no clones 
2L3698 A yes no clones 
2L3730 A yes no clones 
2L3768 A yes no clones 
2L3792 A yes no clones 
2L3794 A yes no clones 
2L3814 A yes no clones 
2L3838 A yes no clones 
2L3854 A yes no clones 
2L3894 A yes no clones 
2L3905 A yes no clones 
2L3907 A yes no clones 
2L3920 A yes no clones 
2L3944 A yes no clones 
2L3949 A yes no clones 
2L3988 A yes no clones 
2L3997 A yes no clones 
2L4048 A yes no clones 
2L4064 A yes no clones 
2L4103 A yes no clones 
2L4108 A yes no clones 
2L4178 A yes no clones 
2L4211 A yes no clones 
2L4222 A yes no clones 
2L4223 A yes no clones 
2L4229 A yes no clones 
2L4252 A yes no clones 
2L4257 A yes no clones 
2L4267 A yes no clones 
2L4304 A yes no clones 
2L4306 A yes no clones 
2L4315 A yes no clones 
2L4337 A yes no clones 
2L4366 A yes no clones 
2L4411 A yes no clones 
2L4450 A yes no clones 
2L4481 A yes no clones 
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2L4578 A yes no clones 
2L4713 A yes no clones 
2L4741 A yes no clones 
2L4745 A yes no clones 
2L0141 B no low number of clones, no positive clones in wing imaginal disc 
2L0224 B yes low number of clones, wt clones in wing imaginal disc 
2L0557 B yes low number of clonal cells 
2L0611 B yes low number of clones 
2L0872 B no low number of clonal cells 
2L0948 B yes low number of clonal cells 
2L0951 B no low number of clonal cells, especially in DT 
2L4739 B yes low number of clonal cells 
2L2629 B  yes low number of clonal cells 
2L4152 B  no low number of clonal cells 
2L1160 B I no extremly low number of clonal cells 
2L1261 B I yes very low number of clones 
2L1901 B I yes very low number of clones 
2L2058 B I yes very low number of clonal cells 
2L2622 B I no very low number of clonal cells 
2L3089 B I no low number of clonal cells 
2L3390 B I yes extremly low number of clonal cells 
2L4332 B I yes no clones/very few clonal cells 
2L4405 B I yes no clones/very few clonal cells 
2L4449 B I yes very low numebr of clonal cells 
2L1399 C yes small clonal cells 
2L1832 C yes small clones   
2L1913 C yes small clonal cells 
2L2101 C yes small clonal cells 
2L2269 C yes small clonal cells 
2L2282 C no  small clonal cells 
2L2553 C yes small clonal cells 
2L2572 C yes small clonal cells 
2L2816 C yes small clonal cells 
2L2976 C yes small clonal cells 
2L3275 C yes small clonal cells 
2L3430 C yes small clonal cells 
2L3547 C yes small clonal cells 
2L3569 C yes small clonal cells 
2L3611 C yes small clonal cells 
2L3651 C yes small clonal cells 
2L3948 C yes small clonal cells 
2L4034 C yes small clonal cells 
2L4744 C yes small clonal cells 
2L0944 C   yes small clonal cells 
2L1714 C I no very small clonal cells  
2L1749 C I yes very small clonal cells 
2L2416 C I yes very small clonal cells 
2L2871 C I yes very small clonal cells 
2L3937 C I yes extremly small clonal cells 
2L4067 C I yes very small clonal cells 
2L1554 C I  yes extremly small clonal cells 
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2L0689 C II ? low number of clones, small clonal cells 
2L1360 C II yes low number of clonal cells, small 
2L1663 C II yes very small clonal cells, low number 
2L1805 C II yes small clonal cells, low number 
2L2073 C II no small clonal cells, low number 
2L2526 C II yes very small clonal cells, low number 
2L2648 C II yes very small clonal cells, low number 
2L2953 C II yes small clonal cells, low number 
2L3278 C II yes low number, small clonal cells 
2L3293 C II no extremly small clonal cells 
2L3301 C II yes extremly small clonal cells, low number 
2L3311 C II yes extremly small clonal cells, low number 
2L3456 C II yes very low number,small clonal cells 
2L3500 C II yes small clonal cells, low number 
2L3642 C II yes extremly small clonal cells, low number 
2L3908 C II yes small clonal cells, very low number 
2L3940 C II yes very small clonal cells, low number 
2L4081 C II yes very small clonal cells, low number 
2L4508 C II yes very small clonal cells, low number 
2L4509 C II no very small clonal cells, low number 
2L0128 D no cells in DT larger than in wt 
2L0196 D no DT narrowed within clonal cells (not fully penetrant) 
2L0372 D no smaller lumen and irregular shape of clonal cells in DT 
2L3090 D yes rounded up clonal cells in DT and secondary branches 
2L3191 D yes irregular lumen in DT at clonal position 
2L4771 D yes bendings of fusion cells in DT, no clonal cells in TB and other fusion cells 
2L1506 D I yes small clonal cells, DT bendings 
2L1687 D I yes bendings of DT at clonal position, smaller clonal cells 
2L2181 D I yes DT bendings 
2L3179 D I yes slight DT bendings 
2L3696 D I yes DT bendings 
2L3910 D I yes DT bendings 
2L4021 D I yes slight DT bendings, very low number of clonal cells in TB 
2L4333 D I yes DT bendings, TB shorter branches 
2L0439 D I  yes bendings of DT at clonal position 
2L2676 D I/E V yes almost no TB, TB with reduced number of branches, slight DT bendings 
2L3146 D II yes small clonal cells, almost only in DT, low number 
2L3680 D II no low number of clonal cells, only in DT 
2L3707 D II yes low number of clonal cells, only in DT 
2L3038 D II  yes small clonal cells, only in DT 
2L0028 D III yes small clones in DT, low number of clones, no positive clones in wing imaginal disc 
2L1693 D III yes small clonal cells in DT, low number 
2L3418 D III yes small clonal cells in DT 
2L3477 D III yes small clones in DT, reduced number of clonal cells in TB 
2L3585 D III yes small clonal cells in DT 
2L2769 D IV yes low number of clonal cells in DT 
2L2875 D IV yes no clonal cells in DT 
2L3602 D IV yes no clonal cells in DT 
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2L1668 E yes abnormally formed TB 
2L1923 E yes wrong formation of TB 
2L2084 E yes thicker lumen in dorsla branches, additional branching points 
2L2806 E no untypical TB branching 
2L2944 E no untypical TB, thicker, with reduced branching 
2L3193 E no abnormally formed TB 
2L3393 E yes abnormally formed TB 
2L3807 E yes abnormal ratio of clonal cells in TB and other types of branches 
2L4105 E yes smaller diameter of TB 
2L4515 E yes smaller diameter of TB 
2L0525 E I yes TB cross/fusion 
2L1030 E I yes intra/inter fusion  and branch crossing in TB 
2L1210 E I no TB cross/fusion, low number of TB 
2L1472 E I no TB crossing, spacing problem in lateral branches 
2L1629 E I no expanded TB, crossed, maybe more branches 
2L1816 E I yes TB crossing  
2L2365 E I yes TB crossing 
2L2408 E I yes TB crossing 
2L2442 E I no TB crossing/fusion 
2L2445 E I no TB crossing/fusion 
2L2646 E I yes TB crossing 
2L2993 E I yes TB crossing 
2L3063 E I yes TB crossing/fusion 
2L3075 E I yes TB crossing 
2L3200 E I no TB crossing, irregular branching 
2L3244 E I yes TB intra - crossing 
2L3294 E I yes TB crossing 
2L3300 E I no TB crossing, maybe expanded 
2L3316 E I no TB crossing, weak, enlarged cell body 
2L3327 E I yes TB crossing/fusion 
2L3469 E I yes TB crossing 
2L4753 E I no TB crossing/fusion 
2L1878 E I  no TB crossing 
2L2022 E I  no TB crossing 
2L0253 E II yes low number of clones, no typical terminal outgrowth, smaller cells, only negative clones in wing imaginal dic 
2L2129 E II yes less or no branches in TB 
2L3120 E II yes reduced branching in TB 
2L3333 E II yes low number of clones, TB reduced number of branches 
2L3458 E II no reduced number of branches in TB 
2L3935 E II yes reduced number of branches in TB 
2L4099 E II yes reduced number of branches in TB 
2L4409 E II no very small clonal cells, lumen formation problems in TB, fewer branches, fewer TB 
2L4485 E II yes small clonal cells, TB formed irregulary, reduced number of branches 
2L4567 E II yes extremly small clonal cells, reduced number of TB, reduced number of branches 
2L4613 E II yes reduced number of branches, small clonal cells and low number 
2L0876 E III no partila formation of lumen in TB, not fully penetrant 
2L2218 E III yes no lumen in TB , almos no branches, very low number of clonal cells 
2L2741 E III yes lumen formation problem in TB, TB fusion/cross 
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2L3152 E III yes almost no clonal cells in TB, if they are no lumen 
2L3260 E III yes no lumen in TB, low number of clonal cells in TB 
2L3340 E III yes lumen formation problem in TB,  
2L3443 E III yes low number of clonal cells, lumen formation problem in TB 
2L3463 E III yes lumen in TB placed on the side, sometimes two lumen in part of branches 
2L3637 E III yes lumen formation problem 
2L3664 E III yes reduced number of branches in TB, small clones, lumen formation problem 
2L3686 E III yes misplaced lumne in TB 
2L3789 E III yes sligth TB lumen formation problem - lumne stops at fine branches 
2L3881 E III yes thicker TB without lumen 
2L4010 E III yes lumen in TB stops at beginning if the branch 
2L4117 E III yes no lumen in TB 
2L4158 E III yes lumen formation problem in TB, change in diameter in transverse connective 
2L4501 E III yes lumen formation problem in TB and secondary branches 
2L4658 E III no no lumen in TB 
2L4765 E III yes very small clonal cells, lumen formation problem in TB, abnormal branching pattern 
2L1475 E IV yes elongated TB 
2L2853 E IV yes expanded TB longer branches 
2L3522 E IV yes expanded TB 
2L4098 E IV no more branches in TB 
2L0507 E V no small clonal cells, few in TB 
2L0508 E V no small clonal cells, few in TB 
2L0957 E V no no clonal cells in TB 
2L1514 E V yes very low number, clonal cells very small, no in TB 
2L1691 E V yes very low number of clones, no in TB 
2L1806 E V yes very low number of clones no in TB 
2L3369 E V yes reduced number of TB 
2L3874 E V yes no clonal cells in TBs 
2L4127 E V yes low number of clonal cells, no clonal cells in TB, small 
2L4324 E V yes no clonal cells in TB 
2L4506 E V yes low number of clonal cells, no clonal cells in TB 
2L4700 E V no no/fewer clonal cells in TB 
2L4737 E V yes almost no clonal cells in TB 
2L0419  yes tracheal histoblasts are smaller if consisting of clonal cells 
2L0445  no wrongly shaped and too small clonal cells at DT and secondary branches
2L1281  yes no clones in epidermal cells, tracheal clones wt 
2L1296  no no clonal cells in epidermis 
2L3574   yes clonal cells only in epidermis 
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Abstract 
 
Many animal organs are built of ramified tubular epithelial structures. How they form and what 
controls branching events, direction of growth and tube size are important questions for 
understanding branch morphogenesis. The Drosophila tracheal (respiratory) system is an excellent 
model to investigate this process. Extensive studies on tracheal development in the last years 
resulted in revealing mechanisms involved in tube formation. However there are still many open 
questions, especially concerning late events of tracheal morphogenesis, such as branching of 
terminal cells during the larval life. Thus we performed a genetic mosaic screen to identified new 
genes involved in tracheal development. As a screening tool the MARCM system was applied and 
mutant lines were examined in third instar larvae. 
Out of 4779 analysed lines 344 showed phenotypes different from the wild type. These lines were 
classified into five general phenotypic classes: A - no mutant clones, B - low number of mutant 
clonal cells, C – small mutant clonal cells, D - dorsal trunk defects, E – terminal branching defects. 
Three phenotypic groups were characterised in more detail – one from class D, showing dorsal 
trunk bendings and consisting of eight alleles (D1), and two from class E, showing defects in 
formation of lumen in terminal cells (E2 and E3), both consist of two alleles.  The phenotypes in 
groups D1 and E3 were mapped to the genomic region of ~190kb and ~160kb respectively.   
Although none of the mutations have been mapped to individual genes and no mechanisms 
explaining different phenotypes could be proposed, the screen provided collection of mutants, 
whose analysis will help in better understanding of cellular processes of tracheal development. 
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9. Zusammenfassung 
 
Viele tierische Organe sind aus Netzwerken verzweigter epithelialer Röhren (Tubuli) aufgebaut. Wie 
diese entstehen und welcher Kontrolle die Bildung von Verzweigungen, deren gerichtetes Wachstum 
sowie die Größe der entstehenden Röhren unterliegen, sind wichtige Fragen zum Verständnis der 
Morphogenese dieser Strukturen. Das Atmungssystem (Tracheensystem) von Drosophila bietet ein 
gutes Modellsystem, um diese Prozesse zu untersuchen. Umfangreiche Studien zur Entwicklung des 
Tracheensystems in den letzten Jahren haben viel zu unserem Verständnis der Mechanismen, die der 
Tubusformation zugrunde liegen, beigetragen. Allerdings sind noch immer viele Fragen offen, 
insbesondere bezüglich der späteren Prozesse der Tracheenentwicklung, wie zum Beispiel die 
Verzweigung der terminalen Zellen während des Larvenstadiums. Wir führten einen genetischen 
Mosaik-Screen durch, um neue Gene zu identifizieren, die an der Tracheenentwicklung beteiligt sind. 
Das MARCM System wurde für den Screen verwendet; die mutanten Linien im dritten Larvenstadium 
untersucht.   
344 von insgesamt 4779 untersuchten Linien zeigten Phänotypen, die sich vom Wildtyp unterschieden. 
Diese Linien wurden in 5 generelle phänotypische Klassen unterteilt: A – keine mutanten Klone, B – 
geringe Anzahl mutanter klonaler Zellen, C – mutante klonale Zellen mit kleiner Zellgröße, D – 
Defekte im Dorsalstamm (dorsal trunk), E – Defekte in der Verzweigung der terminalen Zellen. Drei 
phänotypische Gruppen wurden detaillierter analysiert -  eine der Klasse D, die Krümmungen des 
Dorsalstamms aufwies und aus 8 Allelen bestand (D1), sowie zwei der Klasse E, die Defekte in der 
Lumenbildung in den terminalen Zellen aufwiesen (E2 und E3), beide mit jeweils zwei Allelen. Die 
Phänotypen der Gruppen D1 und E3 wurden der genomischen Region von ∼190 kb resp. ∼160 kb 
zugeordnet.  
Obwohl keine der Mutationen individuellen Genen zugewiesen werden konnte und keine Modelle 
aufgestellt werden konnten, um die unterschiedlichen Phänotypen zu erklären, stellt der Screen 
dennoch eine Sammlung von Mutanten zur Verfügung, deren Analyse dazu beitragen wird, die der 
Tracheenentwicklung zugrunde liegenden zellulären Prozesse besser zu verstehen.  
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